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Summary 
 
 
 
The cardiac OFT is composed of endothelial cells (ECs), smooth muscle cells 
(SMCs), fibroblasts (Fbs) and Cardiomyocytes (CMs) known to derive from neural crest 
and second heart field (SHF) progenitors. The OFT is also covered by a mesothelial sheet 
of arterial mesothelial cells (AMCs) continuous with the epicardium. While the epicardium 
arises from the proepicardium, the early progenitor of AMCs is unknown. 
Using mesothelial and SHF related Cre lines we identified the origin of AMCs to be 
in the dorsal pharyngeal mesoderm. During a systematic analysis of cardiac lineages by 
random clonal labelling in developing mouse hearts, we found that AMCs shared a clonal 
relationship with cells of the great arteries. AMC clones were of different nature along the 
great arteries. On one hand, distal AMCs in both vessels were clonally related to Fbs, 
SMCs and ECs. On the other hand, the proximal AMCs of the Pulmonary artery (PA), 
were clonally related to Fbs, SMCs, CMs and lymphatic endothelial cells (LECs) of the 
ventral part of the heart. These clones however, were never found together with lymphatic 
clones of the dorsal part of the heart suggesting multiple origins for cardiac lymphatic 
vessels. Fate mapping of VEGFR3+ progenitors at different stages showed that whereas 
dorsal lymphatics derive from pre-existing lymphatic vessels, formation of ventral 
lymphatics involves the late recruitment of non-lymphatic cells. Using a range of SHF-
specific Cre lines, we found that SHF-derived cells form ventral but not dorsal cardiac 
lymphatics. These observations suggest that SHF progenitors are recruited in the 
mesothelial-sub-mesothelial region of the PA. To test this hypothesis, we transplanted 
portions of PA mesothelial/sub-mesothelial layers from fluorescent donors into wild type 
E14.5 hearts. Donor tissue invaded the host myocardium, forming lymphatic vessels. The 
exploration of molecular cues involved in the formation of that niche showed that Raldh2 
is downregulated at transcriptional and protein levels in proximal AMCs. Moreover, the 
loss of RA signalling in mesothelial cells resulted in immature lymphatic vessels while an 
excess of RA triggered lymphatic hyper-remodelling.  
These data show that part of the ventral lymphatics form by recruitment of SHF 
progenitors at a vasculogenic niche specified in a low Raldh2 environment. 
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Resumen 
 
 
 
El tracto de salida cardíaco (OFT) está compuesto por células endoteliales (EC), 
células de músculo liso (SMC), fibroblastos (Fbs) y cardiomiocitos (CM) que derivan de 
los progenitores de la cresta neural y del segundo campo cardíaco (SHF). El OFT está 
recubierto por una capa de células mesoteliales arteriales (AMCs) continua al epicardio. 
El epicardio proviene del proepicardio. Sin embargo, el progenitor temprano de las AMCs 
está desconocido. 
Mediante el uso de líneas Cre de mesotelio y de SHF, identificamos el origen de 
las AMCs en el mesodermo faríngeo dorsal. Durante un análisis sistemático de los linajes 
cardíacos mediante el etiquetado clonal aleatorio en corazones de ratones en desarrollo, 
encontramos que las AMCs comparten una relación clonal con las células de las grandes 
arterias. Los clones de AMCs eran diferentes según su posición en las grandes arterias. 
Por un lado, las AMCs distales en ambos vasos eran asociadas clonalmente con Fbs, 
SMC y EC. Por otro lado, las AMC proximales de la arteria pulmonar (AP) eran asociadas 
clonalmente con Fbs, SMC, CM y células endoteliales linfáticas (LEC) de la parte ventral 
del corazón. Sin embargo, estos clones no solapan con los clones linfáticos de la parte 
dorsal del corazón, lo que sugiere múltiples orígenes para los vasos linfáticos cardíacos. 
El trazado de los progenitores VEGFR3 + a diferentes estadios, demostró que los 
linfáticos dorsales derivan de vasos linfáticos preexistentes mientras que la formación de 
linfáticos ventrales implica el reclutamiento tardío de células no linfáticas. Usando un 
abanico de líneas Cre específicas del SHF, Recapitulamos el desarrollo de los linfaticos 
ventrales exclusivamente. Esto sugiere que los progenitores del SHF se reclutan en la 
región mesotelial/sub-mesotelial de la AP. Transplantamos trozos de mesotelio / sub-
mesotelilo de la AP de donantes fluorescentes a corazones de tipo salvaje a E14.5. El 
Tejido donante invadió el miocardio del recipiente, formando vasos linfáticos. La 
exploración de señales moleculares involucradas en la formación de ese nicho mostró 
que Raldh2 está regulado a la baja a nivel transcripcional y proteíco en las AMCs 
proximales. Además, la pérdida de señalización del Ácido Retinoico (AR) en las células 
mesoteliales resultó en vasos linfáticos inmaduros, mientras que un exceso de AR 
desencadenó una hiper-remodelación linfática. 
Estos datos muestran que parte de los linfáticos ventrales se forman mediante el 
reclutamiento de progenitores de SHF en un nicho vasculogénico especificado en 
condiciones de bajo niveles de Raldh2. 
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Introduction 
1.1 A Brief historical aside 
 
The role and function of the heart have been a subject of debate for more than 
0.2000 years as people knew about its existence since ancient times. In the Egyptian, 
Greek and Roman antiquity, the heart was considered as the seat for emotions, courage, 
intelligence and memory, hence the expression “learn by heart”. In the IInd century, the 
Greek physician Galen challenged the theory of Aristotle and other of his ancestors to 
place the brain as the holder of cognitive functions. Heart anatomy became clearer in the 
XVIth century as Leonardo da Vinci represented the human heart with unprecedented 
accuracy (picture.1) and the Spanish theologist Miguel Servet discovered pulmonary 
circulation in 1546. A century later, the English physician William Harvey’s breakthrough 
taught us about the existence of the blood circulation (De Motu Cordis 1628). Surprisingly, 
the dichotomy heart/brain remained for centuries as it had not been firmly established 
Picture 1. Heart and its blood vessels, Leonardo da Vinci 1508 
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which of these organs was responsible for human emotions. It took the onset of the XIXth 
century to start understanding that mental functions are organized in different brain 
regions as postulated by the German neuroanatomist Franz Joseph Gall. The heart is now 
recognised as a vital blood pumping organ and the debate has definitely closed as the 
South African surgeon Christiaan Barnard performed the first successful heart 
transplantation in 1967. Nowadays human hearts are “interchangeable” and death is no 
more pronounced at the arrest of the heartbeat but when brain activity is no longer 
detectable. In spite of it all, the heart remains as a symbol of love and some people, like 
myself, are still compelled to “think with their heart”. 
 
1.2 Heart anatomy and function 
 
The vertebrate heart is the powerful pump which supplies the entire body with 
blood, oxygen and nutrients. Its role is so vital that it is the first organ to form during 
development. It starts contracting shortly after its formation as the need for nutrients and 
waste removal as the embryo grows can no longer be sustained by diffusion. Defects 
affecting heart formation are responsible for a substantial loss of foetuses and embryos 
before birth, accounting for 30% of human pregnancies (Bruneau, 2008). In addition, 
Congenital heart defects (CHDs) are the most common type of birth defects.  According 
to the Centre for Disease Control and prevention, 3% of the population is born with a CHD 
(Fahed et al., 2013; Parker et al., 2010). CHDs range from simple conditions to more 
severe life-threatening symptoms requiring specific treatments. The occurrence of CHDs 
reflects how strict cardiac formation must be orchestrated to produce a heart that remains 
fully functional throughout lifespan. 
 
The mammalian heart is a highly organized structure which can be divided into a 
left and a right compartment. Each compartment is itself composed of two adjacent 
chambers: one atrium and one ventricle (Fig.1). Systemic deoxygenated blood enters the 
right atrium through the superior and inferior caval veins, reaches the right ventricle and 
is pumped out to the lungs via the pulmonary artery. On its way out from the lung, the 
blood which is newly oxygenated, runs through the pulmonary veins to re-enter the heart 
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via the left atrium. The blood passes to the adjacent left ventricle and is expelled through 
the ascending aorta to irrigate the body and the heart itself via the coronary arteries. The 
entrance and exit of blood in each of the four heart chambers is regulated by the opening 
and closing of specific valves (Fig.1).   
 
 
 
 
 
 
 
 
The heart chambers are grossly composed of 3 layers from the outside to the 
inside: 
-the epicardium 
-the myocardium 
Figure 1. The mature mammalian heart and its blood flow. 
The heart is formed of four chambers: the right atrium, the right ventricle, the left ventricle and 
the left atrium. Systemic deoxygenated blood enters the heart through the caval veins into the 
right atrium and passes to the right ventricle to exit through the pulmonary trunk. The blood is 
then oxygenated in the lungs and enters the left ventricle through the pulmonary veins 
connected to the left atrium. Once in the left ventricle, the blood is pumped out through the 
aorta and distributed to the body. 
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-the endocardium.  
All layers contain a variety of specialized cell types. The myocardium contains 
cardiomyocytes, smooth muscle cells/pericytes, fibroblasts, endothelial cells and innate 
immune cells. Heartbeat depends on the work in concert of contractile cells: the 
cardiomyocytes. Cardiomyocyte function is coordinated by electrical impulses regulated 
by cells of the conduction system. Cardiomyocytes virtually occupy the majority of the 
heart volume but only account for about 50% of all cardiac cells (Banerjee et al., 2007). 
Fibroblasts are structural cells which secrete extracellular matrix (ECM) proteins to 
maintain tissue architecture. Endothelial cells are of two types in the heart: cells that cover 
the lumen of arteries, veins and capillaries and endocardial cells that cover the lumen of 
the heart. Smooth muscle cells and pericytes are associated to hearts vessels and 
capillaries, respectively, to regulate changes in vessel pressure. On its external surface, 
the heart is covered by a monolayer of epicardial cells. The epicardium is mostly 
composed of mesothelial cells which are pavement like-cells that line serous cavities 
offering a slippery protecting surface. The epicardium is associated to cell types also 
present in other organs such as macrophages, nerve fibres, glial cells and lymphatic 
endothelial cells (LECs). 
Cardiac structure is the result of tightly regulated developmental processes. 
Understanding Cardiogenesis is thus of importance for the aetiology of CHD and for 
potential stem cell therapies to treat heart failure. From the standpoint of mammalian 
cardiogenesis, the mouse is the best described model. In addition, heart physiology, 
anatomy and development are highly conserved between mice and humans (Moon, 
2008). We will thus describe cardiogenesis referring to mouse models unless otherwise 
stated. 
 
1.3 Embryonic heart development 
 
1.3.1 Formation of the four-chambered heart 
 
The heart is the first organ to form shortly after gastrulation (Fig. 2). The first heart 
progenitors appear at embryonic day E6.5 (E6.5) when epiblast cells ingress through the 
9 
 
primitive streak (PS) to form the lateral plate mesoderm as shown in mouse (Lawson et 
al., 1991; Tam and Behringer, 1997) as well as chick embryos (Kirby, 2007). As cardiac 
cells emerge from the PS they start expressing Mesp1 (Mesoderm Posterior 1), a key 
regulator of cardiac specification ( Saga et al., 1999, 2000; Lescroart et al., 2014). 
Myocardial specification depends on molecular cues from the hypoblast such as 
transforming growth factor family  (TGF-) factors in the chick and from the endoderm in 
the mouse (Nijmeijer et al., 2009). At E7.5, heart precursors consist of two mesodermal 
pools of cells on each side of the ventral mid-line. By embryonic day E7.75 these two 
cardiogenic regions fuse at the mid-line, under the head folds, forming an already beating 
cardiac crescent (Moorman et al., 2003; Wagner and Siddiqui, 2007). The cardiac 
crescent expresses markers of cardiovascular commitment such as Gata4, Nkx2.5, 
Hand2, Mef2c, Tbx20, myocardin (Bondue A. et al., 2008; Bondue A. and Blanpain, 2010). 
The cardiac crescent is a two-layered structure composed of endocardium in the inside 
and myocardium in the outside. The heart tube is originally attached to the body wall via 
the dorsal mesocardium (Abu-Issa and Kirby, 2008; Vincent and Buckingham, 2010). As 
the heart tube elongates it closes dorsally starting from the caudal to the cranial region by 
a ‘zipping like’ process as the dorsal mesocardium breaks down leaving the heart 
‘hanging’ by his poles (Arguello et al. 1975; Moreno-Rodriguez et al. 2006). In parallel, the 
heart tube undergoes rightward looping so that both poles of the tube are aligned on the 
anterior-posterior (AP) axis (Buckingham et al., 2005). The pole moving anteriorly 
becomes the arterial pole while the pole moving posteriorly becomes the venous pole of 
the heart. The atria and inflow region form at the venous pole of the heart while the Ouflow 
tract (OFT) is formed at the arterial pole of the heart. At E10,5 the future atria are still 
connected, so are both ventricles. The connection of each atrium to its respective ventricle 
is made by the atrioventricular canal (AVC). By E14,5 the organization plan of the heart is 
established: 
- the four cardiac chambers are separated by interatrial and interventricular septa.  
- the pulmonary and caval veins take root in the inflow region of the heart. 
- the Pulmonary artery and aorta take root in the the OFT region. - the connections 
between chambers, veins and arteries are delimited by valves for the regulation of blood 
flow. 
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According to the segmental hypothesis, the primary heart tube was thought to 
contain progenitors of all cardiac chambers, organized as independent segments along 
the arterial-venous axis (Davis 1927; Srivastava & Olson 2000). This segmental model of 
myocardial cell regionalization proposes that each segment gives rise to a specific cardiac 
chamber (reviewed in Buckingham M. et al.,2005; Van Den Berg and Moorman, 
2009)).  The ballooning model now shows that the early heart tube is mostly fated to 
become the left ventricle and provides a scaffold for the addition of further cell lineages. 
According to this model, both ventricular chambers balloon out from the outer curvature  
of the looping heart tube (Moorman et al., 2003). 
In the following chapter we will describe the lineages that have been identified to 
contribute to the myocytic and non-myocytic cells of the heart. They are mainly of three 
Figure 2. Overview of early mouse heart development. 
Cardiac mesodermal cells are located in the cardiac crescent under the head folds at E7.5. At 
that stage two cardiac fields are distinguishable: the first heart field (FHF in red) and second 
heart field (SHF in green). At E8.5 the heart tube rapidly elongates undergoing rightward 
looping. At E10.5 different cardiac regions are apparent: the left and right atria (LA and RA), 
the left and right ventricles (LV and RV) and the outflow tract (OFT).  Extracardiac heart 
progenitors are present in the proepicardium (PE) and Neural crest (NC) at E9. The cardiac 
anatomical plan is established at E14.5 as the four heart chambers are separated. The heart 
pumps out blood through the aorta (Ao) and pulmonary artery (PA). Cr: Cranial; Ca: Caudal; 
Epi: Epicardium; R: right; L: left. Cartoon adapted from Stéphane D. Vincent and Margaret E. 
Buckingham,2010). 
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sorts: the cardiogenic mesoderm cells (CMC), the proepicardium (PE), and cardiac neural 
crest cells (CNCCs). 
 
1.3.2 Contribution of cardiac lineages during development 
 
The Second Heart Field 
 
The concept that all prospective cardiac chambers are not present in the heart tube 
was introduced by the work of Viragh and Challice in 1973 as they described cells 
undergoing an epithelial to myocardial transition at the border between the heart tube and 
the adjacent pharyngeal mesoderm (Virágh and Challice, 1973). Later on, De la Cruz and 
colleagues demonstrated that when disconnecting the cephalic end of chick embryonic 
hearts from the body wall, they failed to further elongate (Argüello et al., 1975). In another 
series of experiments, they showed that iron particles placed in the cephalic end of the 
heart tube reached the ventricular septum (separation between both ventricles) at later 
stages (de la Cruz et al., 1977). It took two more decades until three independent teams 
identified an external source of cardiac progenitors in the mesoderm. (Kelly et al., 2001; 
Mjaatvedt et al., 2001; Waldo et al., 2001; reviewed in Kelly, 2012). These progenitors lie 
medially and posteriorly to the heart tube in the pharyngeal mesoderm (Fig. 2). Because 
such cells are added secondarily, they are termed Second Heart Field (SHF) while cells 
of the cardiac crescent are referred to as the First Heart Field (FHF) (Kelly, 2012; Spater 
et al., 2013).  Lineage tracing experiments using the Islet1-Cre line (Cai C.L. et al., 2003) 
as well as retrospective clonal analysis with the nlaacZ reporter gene (Meilhac et al., 2004) 
showed that SHF cells express the LIM homeodomain transcription factor Islet1 (isl1) and 
are added at both the arterial and venous pole of the primary heart tube. Isl1 expression 
is crucial for SHF contribution as isl1 mutants form a linear heart tube that fails to loop and 
elongate (Cai C.L. et al., 2003). Sigolène Meilhac and colleagues used rare random cell 
labelling to perform unbiased cell fate analysis at E8.5 (Meilhac et al., 2003). Clones were 
found restricted to the left ventricle / inflow region or contributing to the outflow or outflow 
/ inflow regions. The first class of clones corresponds to FHF contribution and the second 
class to SHF contribution as defined by Isl1 expression. Altogether these experiments 
show that the FHF mainly gives rise to the left ventricle and atria and shows early 
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expression of myosin light chain 2 Mlc2. The SHF contributes to the right ventricle, Outflow 
tract (OFT), inflow region (venous pole) and part of the atria and expresses isl1 (Fig. 2). 
Further studies identified the SHF as a vast pool of progenitors, itself organised into 
subdomains. 
The experiments of embryo labelling in culture (Kelly et al., 2001; de la Cruz et al., 
1977; Waldo et al., 2005), documented previously, show that SHF progenitors are 
patterned along the antero-posterior axis since the site of labelling in the SHF accurately 
predicts the part of the heart that is labelled in the end. The SHF can indeed be divided in 
subdomains. The Anterior heart field (AHF) contributes to the right ventricle and OFT 
(Kelly R.G. et al., 2001; Waldo et al., 2001; Zaffran S. et al., 2004) and expresses a variety 
of specific transcription factors such as Fgf8, Fgf10, Tbx1, six2 (Zhou et al., 2017) and a 
Mef2c specific enhancer. In contrast, the pSHF predominantly contributes to the venous 
pole and more particularly to atrial and atrioventricular septa as well as to part of the OFT 
(Galli et al., 2008; Bertrand et al., 2011; Rana et al., 2014). The pSHF expresses Hox 
genes such as Hoxb1 (Bertrand et al., 2011; Roux et al., 2015) and other genes also 
present in the FHF like Tbx5 and Osr1 (Xie et al., 2012; Devine et al., 2014). The most 
posterior portion of the SHF mesenchyme is distinct because it does not express the 
transcription factors Nkx2.5. Instead, these cells express Tbx18 and will be giving rise to 
the myocardium of the caval veins (Christoffels et al., 2006). 
T-box-containing transcription 1 (Tbx1) is a major regulator of SHF deployment. 
This gene is the major candidate in 22q11 deletion syndrome or DiGeorge syndrome 
characterised by craniofacial and cardiac defects (Zhang Z. et al., 2006) (Théveniau-
Ruissy et al., 2008). Even though Tbx1 is a marker of AHF, Tbx1 mutation results in 
abnormal development of AHF derivatives as well as pSHF derivatives. Tbx1 null embryos 
result in short and narrow embryonic OFT and present a persistent truncus arteriosus 
(absence of septation between the Aorta and Pulmonary artery) (Jerome and 
Papaioannou, 2001; Théveniau-Ruissy et al., 2008; Rana et al., 2014) due to the 
deregulation in the AHF. Defects accountable to a deregulation of pSHF progenitors also 
occur in Tbx1 null embryos which present atrioventricular septal defects and defects of 
the dorsal mesenchymal protrusion (DMP) (Rana et al., 2014). Moreover, Hoxb1-
expressing progenitor cells fail to contribute to the shortened OFT in Tbx1-/- embryos. 
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Fate mapping of Tbx1 expressing cells revealed contribution to the proximal OFT and 
myocardium at the base of the pulmonary trunk (Brown et al., 2004; Huynh et al., 2007) 
consistent with the heterogeneity of myocardial progenitors in the arterial pole. 
 
SHF cellular contribution 
 
The pharyngeal mesoderm is a source of a variety of cell types as it is capable of 
giving rise to cardiac cells as well as head muscle cells in the embryo (Lescroart et al., 
2010). In the heart, the SHF not only provides cardiomyocytes (Kelly R.G. et al., 2001; 
Waldo et al., 2001; Zaffran S. et al., 2004) but also non-myocytic cells. Ablation 
experiments in chicks and lineage tracing experiments in mice showed that the pharyngeal 
mesoderm is the source of smooth muscle cells at the base of the great arteries (Saga et 
al., 2000; Sun et al., 2007; Waldo et al., 2005). Smooth muscle contribution follows 
myocardial addition from the SHF between stages HH14 and 18 in the chick (Waldo et al., 
2005b; Ward et al., 2005). Endothelial cells are also added at the arterial pole deriving 
from SHF mesoderm of posterior pharyngeal arches (3,4,6) (Wang et al., 2017). 
SHF contribution and specification are spatiotemporal processes in which SHF 
cells are organised along the anterio-posterior axis and are deployed at the hearts poles 
giving rise to different components. Isl1expressing embryonic stem cells (ES) placed in 
culture behave as multipotent progenitors since they result in clonally related clusters of 
cardiomyocytes, endothelial and smooth muscle cells (Moretti et al., 2006). Similarly 
human foetal Isl1+ cells (Laugwitz et al., 2005) give rise to the same cell types (Bu et al., 
2009). SHF cells are also responsible for large parts of the conduction system (Miquerol 
et al., 2013) and coronary arteries ( Théveniau-Ruissy et al., 2008; Chen et al., 2014; Ivins 
et al., 2015). However, it remains unclear whether all SHF progenitors are multipotent and 
whether multipotency is a property of SHF cells in vivo. 
We will now discuss other heart lineages essential for coronary vasculature 
formation. 
 
The Proepicardium, epicardium and Epicardial derived cells (EPDCs) 
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The proepicardial organ (PEO) is a transitory mesodermal structure that forms 
posterior to the venous pole in the dorsal pericardial wall (Männer, 1992) (Fig. 2). Around 
E9.5, cells from the PEO migrate onto the looping heart and encapsulate the myocardium 
to form the epicardium. The epicardium becomes the outermost layer of the heart and is 
composed of mesothelial cells. Around E11, a subpopulation of epicardial cells undergoes 
an epithelial to mesenchymal transition (EMT) regulated by Snail and slug transcription 
factors (von Gise and Pu, 2012) resulting in epicardial derived cells (EPDCs). EPDCs 
invade the subepicardial and myocardial space to generate a variety of cell types 
(Wessels and Perez-Pomares, 2004, Carmona et al., 2010). EPDCs express the 
transcription factors Wt1, Tbx18, Tcf21, scx and Sema3D, as well as the retinoic acid (RA) 
synthesising enzyme Raldh2. 
Retroviral cell labelling in chicks as well as Cre-based lineage tracing experiments 
in mice showed that EPDCs contribute to the coronary blood vasculature and to cardiac 
fibroblasts ( Mikawa and Fischman, 1992; Mikawa and Gourdie, 1996; Pérez-Pomares et 
al., 2002; Guadix et al., 2006; Katz et al., 2012). Besides, EPDCs populate the 
atrioventricular cushions giving rise to the future tricuspid and mitral valves. The annulus 
fibrosus also originates from EPDCs (Dettman et al., 1998, Manner, 1999, Wessels and 
Perez-Pomares, 2004). Contribution of EPDCs to to cardiomyocytes has been described 
but is still controversial since wt1cre and tbx18cre, the lines used to trace the fate of 
epicardial cells, produce recombination of the cardiomyocyte lineage independently of that 
in the epicardium  (Zhou et al., 2008a, Cai et al., 2008, Rudat and Kispert, 2012; Villa del 
Campo et al., 2016). Katz and colleagues however, reported a modest contribution of the 
epicardium to the myocardial lineage using Semaphorin 3D (Sema3D) and Scleraxis (Scx) 
as epicardial cre drivers.  
The epicardium extends until the base of the OFT where the pulmonary artery and 
aorta take root. Both vessels are covered by a sheet of mesothelial cells contiguous with 
the epicardium. Nevertheless, arterial mesothelial cells are not of PE origin (Männer, 
2013; Pérez-Pomares et al., 2003).They have been described instead as derivatives of 
the cephalic pericardium. Their exact origin, function and fate however is still unclear. 
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In addition to cellular contribution, the epicardium provides trophic factors to the 
underlying myocardium, including retinoic acid (RA), fibroblast growth factors (FGFs) and 
signals arising from the extracellular matrix (ECM) ( Niederreither et al., 1999; Chen et al., 
2002; Merki et al., 2005) . Such signals promote the maturation of the myocardium and 
maintain its mitotic activity. Moreover, studies in adult mice, have shown its activation in 
response to organ damage and during regeneration upon injury. Indeed, adult epicardial 
cells resume embryonic programs to create new vasculature (Smart et al., 2007) and 
cardiomyocytes (Smart et al., 2011) after myocardial infarction. 
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Figure 3. Formation of the mesothelium of the heart and great arteries 
Around E9 cells from the proepicardium (yellow) start spreading over the myocardium (grey). 
At E10, cells of the cephalic pericardium (purple) give rise to arterial mesothelial cells (AMCs) 
crawling down the OFT’s surface. By E11.5, the epicardium is covering the majority of the 
heart to the exception of the mesenchymal portion of the OFT. Epicardial cells go through 
EMT producing EPDCs that invade the myocardium (right caged box). These cells give rise to 
the fibroblasts, smooth muscle and endothelial cells of the coronary vessels as well as few 
cardiomyocytes (the epicardium and its derivatives is represented in yellow). In parallel, the 
arterial mesothelium follows its course invading the mesenchymal surface of the OFT (left 
caged box). It is not known whether arterial mesothelial cells contribute to the heart or 
arteries. By E12.5 the heart and OFT are entirely encapsulated by both mesothelia with no 
overlap. At E14.5 the epicardium and AMCs share a border at the frontier between the 
myocardium and the great arteries. AP: Arterial pole, VP: Venous pole, OFT: Outflow tract, 
RA: Right atrium, LA: Left atrium, RV: Right ventricle, LV: Left ventricle, Ao: Aorta, PA: 
Pulmonary artery. 
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The cardiac Neural crest cells (NCs) 
 
The neural crest is a population of multipotent progenitors arising from the dorsal 
neural tube at mid-gestation between the mid-diencephalon and the posterior border of 
somite 3 (Keyte and Hutson, 2012). The properties of cardiac neural crest cells (CNCCs) 
were discovered by Margaret Kirby and colleagues in 1983. Using quail-chick chimeras 
and ablation experiments in avian embryos, they found that CNCCs delaminate and 
migrate towards the heart, invading the mesodermal core of the pharyngeal arches 3, 4, 
and 6 (Kirby et al., 1983) (Fig. 3). In mice, cre-lox based strategies were later employed 
to trace the fate of neural crest cells using Wnt1-cre, Pax3-cre, P0-cre, and PlexinA2-cre 
(Brown etal.,2001; Jiang etal.,2000; Leeetal.,1997).  
CNCCs contribute to the smooth muscle of the pharyngeal arch arteries at the 
arterial pole of the heart around E10.5 in mice (Fig. 3) (Bergwerff et al., 1998). Neural 
crest cells from the arches migrate to the arterial pole of the heart and induce outflow tract 
remodelling around E12.5. During OFT remodelling, extracellular matrix (ECM) 
components are secreted into the space between the endothelial and myocardial layers 
forming the so called “cardiac jelly”. The cardiac jelly is then colonized by mesenchymal 
cells derived by EMT from the OFT endothelium and the neural crest to form the 
endocardial cushions, bulks of the future semilunar valve leaflets. (Eisenberg and 
Markwald, 1995; Markwald et al., 1981; Sugishita et al., 2004). The swelling of these 
cushions is thought to promote the fusion of endothelial cells at the centre of the OFT 
thereby giving rise to the aorticopulmonary septum ( reviewed by  Navarro-Aragall et al., 
2018).The aorticopulmonary septum divides the truncus arteriosus (common arterial 
outflow) into the base of the pulmonary artery and aorta (Waldo et al., 1998, 1999).  SHF-
derived SMCs and myocardium from the OFT wall populate the emerging septum to 
complete septation through myocardialisation, a process by which the septum becomes 
muscular (Kelly et al., 2001; van den Hoff et al., 1999). The aorticopulmonary septum later 
attaches to the IVS sealing the base of the aorta to the left ventricle and the base of the 
pulmonary artery to the right ventricle. CNCCs further contribute to heart development 
providing a variety of cell types. Indeed, the distal smooth muscle layer of the great 
arteries (Fig. 2) as well as the smooth muscle layer of the coronary arteries at the base of 
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the heart and in the IVS are of neural crest origin (Arima et al., 2012). Moreover, CNCCs 
give rise to the entire parasympathetic innervation of the heart (Kirby and Stewart, 1983).  
Multiple signalling pathways are implicated in CNCCs migration and specification, 
the major players being BMP, Wnt, FGF-8 and semaphorin signalling. In the absence of 
neural crest, outflow tract septation is compromised leading to persistent truncus 
arteriosus (PTA) or common arterial trunk (CAT) (Hutson and Kirby, 2007). This condition 
causes the mixing of oxygenated and deoxygenated blood which is lethal, unless 
surgically corrected shortly after birth. CNCCs ablation also affects SHF’s addition leading 
to a shortened OFT and heart looping defects. This phenotype is mostly due to altered 
FGF-8 levels, which keeps SHF progenitors in a proliferative state that impedes their 
further migration and differentiation (Waldo et al. 2005; Ilagan et al. 2006; Scholl and Kirby 
2009). 
We have summarised the origin of the myocytic as well as non-myocytic cells of 
the heart and their early origin. However, cardiac cells added to the heart during late 
development can also have a crucial role. It is the case of the embryonic lymphatic system 
which have received little attention as compared to the blood vessels. We will thus discuss 
the formation, function and origin of the lymphatic system in the next chapter. 
 
1.4.1 The cardiac lymphatics, an important component of the heart for a long time in 
oblivion 
 
The lymphatic vasculature: development and function 
 
Lymphatic vessels are crucial for organ homeostasis through the transportation of 
immune cells, lipids and toxins and drainage of interstitial fluids (Harvey and Oliver, 2004). 
The origin of the lymphatic vasculature is yet the center of a century-old debate.  
Performing ink injection experiments in pig embryos, Florence Sabin described a 
centrifugal model in which endothelial cells bud from the cardinal veins to form the entire 
lymphatic vasculature (Sabin, 1902). According to this model, the entire peripheral 
lymphatic vasculature develops by endothelial sprouting and remodeling of primarily 
formed lymph sacs (angiogenesis). A few years later, Huntington and McClure reported a 
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centripetal theory in which lymph primordia derive de novo from the mesenchyme 
independently of veins (vasculogenesis) (Huntington and McClure, 1910). The 
reconversion of blood circulating cells to a lymphatic fate has been proposed more 
recently (Maruyama et al., 2005; Sebzda et al., 2006). In agreement with Sabin’s model, 
veins are now commonly accepted as the main source for lymphatic vessels in zebrafish 
(Küchler et al., 2006; Okuda et al., 2012; Yaniv et al., 2006) and mouse models 
(Srinivasan et al., 2007; Yang et al., 2012).  
Murine LECs specify during mid-gestation in the wall of the anterior cardinal veins. 
At day E9.75, a subpopulation of venous endothelial cells acquires a lymphatic progenitor 
identity as the result of COUP-TFII, Sox18 and Prox1 transcription factor expression 
(François et al., 2008; Lee et al., 2009; Sabin, 1902; Srinivasan et al., 2007; Wigle et al., 
2002). (Fig. 3). These cells delaminate from the veins to form lymphatic primordia or lymph 
sacs. The lymphatic vasculature originates from the further sprouting of the cardinal veins, 
lymph sacs and inter-somitic vessels (ISVs) (François et al., 2012; Yang et al., 2012) (Fig. 
3). 
Prospero‐related transcription factor Prox1 has been identified as the key 
determinant of lymphatic cell fate (Hong et al., 2002; Johnson et al., 2008). In Prox1-null 
embryos, sprouting from the veins is still observed but vascular sprouts present blood 
rather than lymphatic endothelial characteristics (Wigle and Oliver, 1999; Wigle et al., 
2002). As a result, Prox1-deficient mice are devoid of lymphatic vasculature (Wigle and 
Oliver, 1999) reflecting a failure in lymphatic specification (Wigle et al., 2002). 
Reciprocally, Prox1 overexpression is sufficient to direct endothelial cells (ECs) towards 
a lymphatic fate both in vitro (Hong et al., 2002) and in vivo (Kim et al., 2010). 
The cardinal veins are certainly the main source of lymphatic vasculature however, 
various studies support an alternative mesenchymal source for lymphatic endothelial cells 
(LECs)(Buttler et al., 2006; Ny et al., 2005; Papoutsi et al., 2001; Schneider et al., 1999; 
Wilting et al., 2000a, 2006) (Fig.3). Moreoever LECs of different organs like the heart 
(Klotz et al., 2015), the skin (Martinez-corral et al., 2015; Pichol-Thievend et al., 2018) and 
the mesentery (Stanczuk et al., 2015) were shown to have, at least in part, alternative 
developmental origins. We are only starting to understand the molecular, developmental 
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and functional differences endowing lymphatic vessels in different organs. Little is known 
about organ lymphatic patterning and its origin as lymphatic vessels have for a long time 
been seen as passive conduits returning tissue fluids to the blood circulation. We now 
know that organ lymphatics play major physiological and pathophysiological tissue-
specific roles. In particular, cardiac lymphatic disturbance leads to heart defects such as 
endocardial edema, cardiac valve deformation, coronary arterial injury, conduction 
alterations, fibrosis, and poor heart performance in animal and human heart 
studies.(Ludwig et al., 1997; Wang et al., 2009) (Miller et al., 1964; Kline et al., 1964; Xu 
et al., 2007). Reciprocally, lymphangiogenesis can improve heart function after injury ( 
Taira et al., 1990; Klotz et al., 2015). Getting insights into cardiac lymphatics and their 
origin has thus gained importance in the etiology of cardiac diseases and the field of organ 
repair.  
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Figure 4. Specification and development of the lymphatic system. 
Around E9 the expression of Coup-TFII, a venous identity marker, triggers the expression of 
Sox18 in a subset of cardinal vein endothelial cells (pink). Sox18 directly activates Prox1 
expression forming “prox1-rich clusters” (PRCs) distributed along the cardinal veins. Lymph 
sacs, originate from the PRCs between E10-E11.5. Prox1 expression also triggers the 
formation of lymphatic structures in the inter-somitic vessels (ISVs). The lymphatic 
vasculature (in green) forms by sprouting from the PRCs, the lymph sacs and the ISVs. 
Sprouting, proliferation and migration of LECs away from the cardinal veins depends on 
vascular endothelial growth factor receptor 3 (Vegfr-3) expression. 
(Cartoon adapted from Ying Yang et al. 2012). 
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The cardiac lymphatic system 
 
Cardiac lymphatics were initially described by Olaus Rüdbeck in 1653 and further 
studied two centuries later by the anatomist Constant Sappey followed by Lewis R. Shore 
at the beginning of the 20th century. Studies in monkeys, rodents, and birds showed that 
cardiac lymphatic vasculature development succeeds that of the coronary blood vessels 
(Flaht et al., 2012; Wilting et al., 2000b). In mammals, the flow of lymph through the 
cardiac lymphatic vessels depends on heart contraction (Alexander et al., 1998; Levick, 
1990; Mehlhorn et al., 1995). In the adult, lymph flows throughout three plexuses located 
in the sub-endocardium, myocardium, and sub-epicardium (Ruszynak et al., 1969). These 
plexuses feed into larger lymphatic vessels that follow the path of the main coronary 
arteries. The lymph returns to the venous system at the junction with the thoracic duct and 
subclavian vein. Development of the murine cardiac lymphatic plexus is limited to the 
subepicardial area before birth. Postnatally, this plexus reaches the myocardium and sub-
endocardium following a base-to-apex gradient. Cardiac LECs as well as systemic LECs 
are characterised by the expression of Prox-1, Lyve-1, VEGFR3, Podoplanin, VEGFR2, 
CD144, CD31 and Tie2 (Flaht-Zabost et al., 2014; Karunamuni et al., 2010). VEGFR3 has 
been shown to be crucial for cardiac lymphatic specification even though it is also 
expressed in BECs until E14.5 (Hägerling et al., 2013; Kaipainen et al., 1995). Mice 
expressing a soluble VEGFR3 protein were used to trap the VEGFR3 ligands, VEGFC / 
VEGFD, inhibiting the VEGFR3 pathway. Transgenic mice developed lymphatic 
hypoplasia in many organs including the heart and presented a regression of already 
existing lymphatic vessels (Mäkinen et al., 2001). As a consequence, mice develop severe 
prenatal and postnatal oedema, including pericardial fluid accumulation. Another set of 
experiments knocking out VEGFC resulted in the blockage of lymph sac formation, 
reflecting the role of VEGFR3 signalling in LEC sprouting from the cardinal veins 
(Kaipainen et al., 1995; Karkkainen et al., 2004). 
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Direct connections of the developing cardiac lymphatics with the jugular lymphatic 
sac (JLS) were noted by Kampmeier in 1928, arguing for a venous origin of cardiac LECs. 
Recent work by Klotz and colleagues showed that most of the lymphatic vasculature in 
the heart is of venous origin using a Tie2-Cre transgene (Klotz et al., 2015). However, the 
group observed incomplete recombination of cardiac LECs by Tie2-Cre recombination, 
Figure 5. Prenatal cardiac lymphatic system organisation in mammals. 
In the mammalian heart, three plexuses have been identified: the right coronary lymphatic 
follows the path of the right coronary artery, runs upwards to the right side of the pulmonary 
trunk, enters the mediastinal lymph node (LN), continues superiorly through the paratracheal 
LNs and drain into the right lymph sac (black arrows). The anterior interventricular and left 
marginal trunks originate in the left ventricle, follow the path of the left coronary artery, enter 
the tracheobronchial LN and drains into the right jugular lymph sac (white arrows). Lymph 
from the posterior interventricular trunk runs along the coronary sinus in the atrioventricular 
sulcus of the dorsal aspect of the heart and reaches the paratracheal lymph nodes (red 
arrows). All efferent extra-cardiac collectors finish their path in the thoracic duct. All lymphatic 
key players are represented in green. LN: Lymph node. (Cartoon adapted from E. 
Brakenhielm and K. Alitalo ,2018). 
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suggesting that not all cardiac lymphatics are of venous origin. They reported instead the 
possible origin of cardiac LECs from the Yolk Sac (YS) haemogenic endothelium using 
fate mapping of Pdgfr + progenitors. However, Ulvmar and colleagues later 
demonstrated that Pdgfr-Cre transgene cannot be used to trace non-venous progenitors 
as it recombines part of the cardinal vein and jugular lymph sacs (Ulvmar et al., 2016). 
These results indicate substantial heterogeneity of cardiac lymphatic cells and highlights 
the limitations in determining the origins and mechanisms of lymphatic vasculature 
development.  In rodent and avian hearts, lymphatic vessel formation has been suggested 
to originate from Prox-1-positive cells/strands migrating along the great arteries (Flaht et 
al., 2012; Karunamuni et al., 2010; Wilting et al., 2007), long after the onset of coronary 
vessel formation. More generally, these data illustrate the limitations of using constitutive 
Cre lines in lineage tracing experiments, and the need of alternative methods describe the 
origin of cardiac lymphatic vessels. As a result, understanding the mechanisms and origins 
of the cardiac lymphatic system demands further analysis. 
 
1.4.1 The role of Retinoic signalling in the four chambered-heart 
 
The effects of Retinoic acid (RA), the active metabolite of vitamin A, in cardiac 
development have been mostly studied in early embryos since RA signalling is crucial for 
SHF deployment and posterior domain delimitation (Ryckebusch et al., 2008). In the 
epicardium, RA signalling regulates myocardial proliferation (Chen TH et al., 2002; 
Stuckmann et al., 2003). RA signalling in the epicardium depends on the retinaldehyde 
dehydrogenase (Raldh2) enzyme responsible for RA synthesis. Raldh2 is highly 
expressed in the epicardium but not in the myocardium (Moss et al., 1998) since the 
mesothelial gene Wt1 activates its expression (Guadix et al., 2011). Raldh2−/− mutant 
hearts present reduced myocardial density (Lin et al., 2010) and a downregulation of Fgf 
signalling, important for myocardial growth. In addition, mutation of the retinoid X receptor 
RXR, affects epicardial EMT thus compromising coronary artery development (Lin et al., 
2010). Wang and colleagues found that pharmacological inhibition of RA synthesis led to 
myocardial thinning and aberrant coronary vessel formation/ remodelling. Interestingly, 
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excessive RA levels in mice deficient for the retinaldehyde reductase DHRS3 also resulted 
in altered coronary vessel morphology and reduction in coronary density and heart 
coverage (Wang et al., 2018a).  
The role of RA on cardiac lymphatic development has not been investigated yet. 
However, a role for RA in lymphangiogenesis has been suggested by studies showing 
that exposing developing embryos to excessive doses of RA increased the number of 
Prox1-positive LEC precursor cells in mouse and Xenopus embryos (Marino et al., 2011). 
Moreover, RA has been shown to promote lymphatic vascular regeneration in a mouse 
model of lymphedema (Choi et al., 2012). Interestingly, endothelial cells of the cardinal 
vein exhibit asymmetric RA levels. The region of LEC progenitor specification exhibits low 
levels of RA as compared to the ventral side of the cardinal vein (Bowles et al., 2014). 
Consistently the dorsal portion of the cardinal veins (Lymphatic specification territory) 
expresses the RA-degrading enzyme Cyp26 while the ventral portion expresses Raldh2. 
In addition, excessive RA levels in Cyp26b1−/− mutants result in enlarged lymph sacs. 
Conversely, the inhibition of RA signalling in Cyp26b1 gain of function showed alteration 
in lymph sac formation. These data, are calling for the investigation of RA role in cardiac 
lymphangiogenesis since they suggest that low RA levels are necessary for lymphatic 
progenitor specification, while higher levels would allow lymphatic sprouting and 
expansion.  
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Objectives 
 
 
The doctoral thesis aimed at describing the lineage tree of the heart during 
development. A broad analysis of heart lineages taking into account all cardiac lineages 
had never been performed before. Moreover, it was not clear how cardiac cell types relate 
to each other and if cardiac lineages are multipotent at the heart tube stage. At the light 
of recent studies about the SHF as a potential multipotent source of cardiac progenitors 
as well as compelling evidence for a heterogeneous origin of cardiac lymphatic endothelial 
cells the main objectives of this study were as follow: 
 
-  Generating a bank of clones for the identification of heart lineages. 
 
- Explore the differences between epicardial clones and arterial mesothelial clones in 
terms of contribution and origin. 
 
- Check if all the vascular cells of the great arteries derive from multipotent progenitors in 
the pharyngeal mesoderm. 
 
- Investigate the dynamics of lymphatic formation through the study of cardiac lymphatic 
clones. 
 
- Confirm or refute hypotheses, based on random single cell labelling, with the use of 
tissue specific -Cre lines. 
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Results 
 
1. Random retrospective clonal analysis successfully targets heart progenitors 
We first wanted to understand the variety and potential of cardiac progenitors, at 
the heart tube stage. To target all cardiac progenitors in an unbiased manner, we 
employed random single cell labelling. We used transgenic mice carrying a tamoxifen 
inducible Cre recombinase (Polr2a-CreERT2 named RERT) as well as two reporters 
(Rosa26R-LacZ and Rosa26R-EYFP) (Fig. 6A). All transgenes were driven by ubiquitous 
promoters so that every cell of the embryo is susceptible to recombine and express one 
of the reporters. Tamoxifen was administered to mice at E8.5 to trigger permanent reporter 
expression in few embryonic cells and their progeny. Embryos were harvested at E14.5 
when the organization plan of the heart is established and heart lineages are advanced in 
differentiation. Since Cre-mediated recombination is tamoxifen dose-dependent we first 
titrated the tamoxifen dose necessary to label single cell progenitors at clonal density. The 
ideal dose should be high enough to trigger the recombination of various cells but low 
enough for their progeny not to overlap during embryonic tissue growth.  
We initially administered 0.15mg of tamoxifen to pregnant mice. We were able to 
successfully target heart progenitors since YFP+ (brown) or LacZ+ (blue) cells could be 
recovered in the heart of various embryos at E14.5 (Fig. 6B-D). However, no YFP/ LacZ 
double positive cells were ever found. This shows independent recombination of the YFP 
and LacZ reporters. Moreover, recombined cells were mostly found as single-reporter 
coherent cell clusters in the heart, indicating that we generated a large proportion of clonal 
cell groups (Fig. 6E-E’’).  
Recombination is achieved at clonal density when a cluster of labelled cells can be 
considered as clonal with high confidence. We thus considered clusters of labelled cells 
(as isolated coherent group of cells) and assessed whether they were clonal (Fig. 6E,E’’) 
according to their colour. Clusters of cells containing YFP+ as well as LacZ+ cells (defined 
as bicolour clusters) originate from the recombination of independent progenitors followed 
by the spatial overlap of their progeny during tissue growth. We thus estimated the 
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frequency of bicolour clusters in order to choose the appropriate tamoxifen dose to 
perform clonal analysis.  
 
Figure 6. Retrospective clonal analysis: experimental setting. 
(A) Transgenic mouse embryos with a tamoxifen inducible Cre recombinase (RERT) and two 
reporters (Rosa26R-LacZ; Rosa26R-EYFP).  All constructs are driven by ubiquitous regulatory 
regions so that any embryonic cell can be randomly labelled. A low dose of tamoxifen was 
administered to pregnant females at E8.5 to trigger few labelling events. Labelled cells are 
analysed at E14.5.Cardiomyocytes (B), fibroblasts (C) and endothelial cells (D) were found 
(arrowheads).Nuclei were counterstained with hematoxylin (grey/purple). (E) LacZ+ and YFP+ 
clusters can be viewed as blue and brown clusters in whole mount. (E’,E’’) high magnification 
of boxed area in E. (F) Comparison of the occurrence of bicolour clusters in function of the 
number of clusters per heart using two different tamoxifen doses (blue: 0.15mg, pink: 0.675mg). 
(G) Frequency of LacZ+ vs YFP+ and bicolour clusters in all litters. Paired t test **p= 0.015. (H) 
transversal section of a E9.5 RERT embryo induced at E8.5 with a high dose of tamoxifen. (I) 
Quantification of the embryonic surface recombined into LacZ vs YFP. ****p < 0.0001. Cr: 
Cranial; Ca: Caudal; R: right; L: left; 4OHT : 4 hydroxy-Tamoxifen (A), TropT: Troponin T (B), 
Pulmonary artery (PA); RA: Right atrium; LA: Left atrium; RV: Right ventricle; Left ventricle (E). 
Scale bar: 200m. (E). 
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The administration of 0.15mg of tamoxifen produced a significant number of 
bicolour clusters, we thus lowered the tamoxifen dose to 0.0675mg. As expected, the 
administration of 0.0675mg of tamoxifen resulted in hearts with fewer bicolour clusters 
(Fig. 6F). As a result, we generated a collection of 737 E14.5 hearts using 0.0675mg of 
tamoxifen to perform clonal analysis. The frequency of LacZ+ cell clusters was higher 
than that of YFP+ cell clusters (Fig. 6G). We thus sought to determine the frequency of 
recombination of each reporter for future calculations used to infer or reject clonal 
relationships.  Embryos were induced with a high dose of tamoxifen (1mg) at E8.5 and 
harvested a day after so that the map of positive cells would directly reflect the efficiency 
of recombination. LacZ + cells represented 69.42% of the recombined area compared to 
30.57% for YFP+ cells, confirming a differential recombination efficiency (Fig. 6H).  
We experimentally determined the frequency of bicolour clusters in the collection 
as 0.038 (Fig. 6G). Bicolour clusters represent only part of all polyclonal clusters, because 
independent progenitors can also be recombined in the same colour by chance. The 
frequency of mono-colour polyclonal clusters is estimated as a function of the frequency 
of bicolour clusters and the frequencies of single-colour clusters, which is biased towards 
the production of LacZ+ clusters (see materials and methods).  The estimated frequency 
is 0,038X1.95=0,074, meaning that mono-colour cell clusters have an estimated 92.3% 
chance to be clonal.  
The collection of hearts was screened for clusters of labelled cells. Each cluster 
was systematically assigned an ID and characterized in whole mount and on sections 
according to its colour, cell type(s) and anatomical position. As expected, our method 
targeted all cardiac lineages since all cardiac cell types were labelled. A general primary 
analysis of all cardiac lineages led us to focus on clones which contained different cell 
types and whose origin and specification were still unclear. Cell clusters were classified 
according to the cell type(s) they contained such as: Cardiomyocytes (CM), endocardial 
cells, Endothelial cells (ECs), Fibroblasts (Fbs), valve mesenchymal cells (valv) Smooth 
muscle cells (SMCs), epicardial cells and arterial mesothelial cells (AMCs). Strikingly, 
approximately 80% of clones consisted of a single cell type showing that as early as E9, 
most heart progenitors are already specified and maintain lineage decisions until E14.5. 
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As expected, heterogeneous clones were found in the Outflow tract (OFT), in the 
epicardium and in the valves. On one hand, the OFT region is known to derive from 
multipotent sources of progenitors: The Second heart field (SHF) and the Cardiac neural 
crest cells (CNCCs). On the other hand, the epicardium is known to undergo Epithelial to 
mesenchymal transition (EMT) after colonizing the myocardial surface and provide the 
heart with smooth muscle cells, fibroblasts, endothelial cells and according to some 
studies, cardiomyocytes.  
The epicardium extends up to the base of the OFT where the pulmonary artery and 
aorta take root. Both vessels are covered by a sheet of mesothelial cells contiguous and 
continuous with the epicardium. We first sought to confirm what had previously been 
described in chick embryos ( Pérez-Pomares et al., 2003; Männer, 2013)(Männer, 2013; 
Pérez-Pomares et al., 2003) by ruling out the possible lineage relationship between the 
epicardium and Arterial mesothelial cells (AMCs). We later investigated the lineage 
relationship between AMCs with cells of the great arteries and the heart, which had not 
been described before.  
2. The epicardium and arterial mesothelium do not belong to the same lineage 
 
In order to understand the lineage relationship between epicardium and AMCs, we 
screened the collection of hearts for AMC and epicardial clones. If epicardial cells and 
AMCs are related, we should be able to observe single clones containing both mesothelial 
types at frequencies above those resulting from random polyclonality. We first studied the 
distribution of labelled cells in the epicardium and the mesothelium of the great arteries 
(Fig. 7). From the collection of 737 hearts, 82 (~11%) contained exclusively epicardial 
clusters, 10 (~1.4%) contained exclusively AMC clusters and 13 (~1.8%) contained both 
(Fig. 7A-C). The distribution pattern of epicardial clones is consistent with their 
proepicardial origin. Epicardial clones appear as large groups of cells colocalizing the 
surface of the heart as well as the sub-epicardial space (Fig.7B-B’; S1A-F). In addition, 
various epicardial clusters were found within a same heart.  For hearts containing more 
than one epicardial cluster, the frequency of colour coincidence between clusters co-
occurring in the same heart was much higher than expected for random independent 
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events and 7 hearts with 4-6 colour-coincident clusters were found (Fig. S1A-F). These 
data suggest a clonal origin of single-colour multiple clusters found in the epicardium. The 
results are compatible with the recombination of single cells in the E9 proepicardium and 
their proliferation before  colonization of the heart surface at different locations. 
Furthermore, these results show that single proepicardial cells proliferate, migrate and 
mix extensively with neighbours during myocardial surface colonization. The absence of 
clusters extending across the border between arteries and myocardium also suggested a 
lineage restriction between AMCs and epicardium.  To further study this aspect, we 
determined the colour coincidence between AMC and epicardial clusters in the 12 hearts 
in which both were observed. In this sample, the colour of all epicardial clusters within a 
same heart was the same, despite the fact that 5 out of 12 hearts contained more than 
two clusters. In only 5/12 hearts there was a colour match between AMC and epicardial 
clusters, while in 7/12 hearts the colours did not match. Even when the colours between 
AMCs and epicardial cells did not match 3 and 4 colour-matched epicardial clusters could 
be found (two hearts). These results are compatible with random independent 
recombination of AMC and epicardial precursors, as the expected matched/non-matched 
proportion deduced from the recombination frequencies is 5.09/6.91, assuming a single 
recombination event in each precursor type. 
To corroborate the results obtained by clonal analysis we used the tamoxifen 
inducible mesothelial specific WT1-creERT2 line (Fig. 7D,E) and induced recombination 
at different stages. Since WT1 is expressed in both populations, we reasoned that the 
timing of labelling of the two populations should depend on whether they originate from 
single or distinct populations.   Detection of the Oestrogen receptor protein (ER) by 
immunofluorescence at E9 in WT1creERT2 embryos, confirmed that Cre recombinase is 
expressed in the proepicardium (Fig. 7F,F’’) and in few epicardial cells (Fig. 7F,F’) at the 
moment of induction. Therefore, at this stage, only the proepicardium and no other 
mesothelial lineages express Wt1Cre.  We thus administered tamoxifen at E8.5 to trigger 
Cre-mediated recombination in proepicardial and epicardial cells. As expected, a 
significant number of epicardial cells were labelled in the ventricles and atria (Fig. 7D). In 
the Outflow tract (OFT), however, no positive cells could be observed (Fig. 7D). These 
data not only show that AMCs are not coming from the proepicardium but also that 
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epicardial cells are not capable of reaching the great arteries. It therefore suggests the 
existence of a lineage restriction boundary at the interface between the myocardium and 
the great arteries.  
These results prompted us to investigate when AMCs appear in the OFT. After 
performing WT1 immunofluorescence in embryos ranging from E8 to E13, we were able 
to observe the first AMCs around E10.5/E11 (Fig. S2 A,B arrowheads). We thus wondered 
if we could target AMCs by inducing WT1creERT2 embryos at E9.5 (Fig. 7E). In that 
setting, some LacZ+ AMCs were observed in the great arteries of E14.5 embryos (Fig. 
7E). To challenge the work of J.M. Perez Pomares and colleagues, we assessed the 
possible cephalic pericardial origin of AMCs. To do so, we analysed ER protein location 
at E10 (presumed stage of maximal induction after E9.5 TM injection). In addition to 
epicardial cells (Fig. 7G,G’’), some pericardial cells expressed the Cre recombinase (Fig. 
7G,G’). These results show the pericardial origin of the OFT mesothelium, which agrees 
with previous observations in chick embryos (Pérez-Pomares et al., 2003). 
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3. AMCs derive from the splanchnic mesoderm related to the Second heart field 
The cephalic pericardium, because of its location, is most likely derived from the 
splanchnic mesoderm related to the Second heart field (SHF). In addition, OFT cells such 
as myocardial, smooth muscle and endothelial cells  are known to derive from SHF 
progenitors (Kelly et al., 2001; Sun et al., 2007; Wang et al., 2017). We therefore 
investigated the possibility of a SHF-related origin for AMCs. To do so, we used various 
Cre lines labelling SHF derivatives and related splanchnic lineages and checked if they 
labelled AMCs. Using the constitutive Mef2c-AHF-Cre transgene line, combined with the 
ROSA26R-TdTomato (Tom) reporter, we observed that the entire mesothelium of the 
great arteries was labelled (WT1/Tom double positive cells) (Fig. 8A,A’,B). Reciprocally, 
labelled cells were not found extensively in the epicardium, however some labelling was 
detected in the epicardium of the ventricles in 3/6 hearts (Fig. 8A,A’,B). Since Mef2c-cre 
recombines a variety of cardiac progenitors, we hypothesized that some hearts exhibited 
Tom + epicardial cells due to residual recombination in the proepicardium (Fig. 8B). 
Indeed, the proepicardium of 2/6 of the embryos analysed at E9.5 had Tom + cells in the 
proepicardium (Fig. 8B). These events of recombination in the proepicardium can thus 
Figure 7. Arterial mesothelial clones are of non-proepicardial origin 
(A) Whole mount ventral view of a specimen of the collection. (A’) high magnification of the 
OFT area specified with a cross in A. (A’’) Section of A’ confirming the absence of YFP+ cells 
in AMCs. (B) Whole mount dorsal view of the same heart. (B’) high magnification of a YFP+ 
epicardial clone seen in B (area of the star). (B’’) frontal section of the same area revealing 
YFP+ epicardial cells and EPDCs. (C) Diagram of the hearts classified according to three 
categories: Hearts that contain AMCs in the Aorta (blue circle), Pulmonary artery (yellow circle) 
or epicardial clones (pink circle). The rest of the collection is indicated outside of the circles. 
Hearts with more than one category are at the intersection of the circles. The polka-dot and 
striped areas indicate if AMCs and epicardial cells are of a same or of a different colour 
respectively. (D-G’’) samples from Wt1creERT2 embryos. E14.5 hearts in (D) and (E) 
correspond to embryos induced at E8.5 and E9.5 respectively. In D no AMCs can be observed 
in contrast to E. The dashed lines represent the border of the myocardium with the great 
arteries. (F-F’’) and (G-G’’) show the localization of the Cre recombinase (ER) in red. The 
myocardium can be appreciated in green. (F’) and (G’’) are high magnifications of ER+ 
epicardial cells seen in the boxed area of (F) and (G) respectively. (F’’) and (G’) are high 
magnifications of ER+ proepicardial cells and pericardial cells (arrowheads) seen in the boxed 
area of (F) and (G) respectively. All scale bars: 100m. Ao: Aorta; PA: Pulmonary artery; RA: 
Right atrium; LA: Left atrium; RV: Right ventricle; Left ventricle. Ms: Mesothelium (C). TropT: 
Troponin T; ER: Oestrogen receptor (F,G). 
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account for the number of hearts with Tom + epicardial cells at E14.5. In contrast, 100% 
of E14.5 hearts presented Tom + AMCs, suggesting their origin in lineages related to the 
anterior SHF (Fig. 8A,A’,B). Tom + To further verify the specificity of AMCs to SHF-related 
lineages, we used the Rosa26R-TdTomato reporter recombined with isl1-Cre, which 
labels the SHF and related splanchnic cells. The observation of such hearts by confocal 
microscopy revealed the presence of Tom + AMCs along the great arteries (Fig. 8C,C’). 
In order to confirm these results, we sought to trace the fate of single SHF progenitors 
labelled at E8.5. To do so, we used the tamoxifen inducible isl1-mER-Cre-mER line with 
the Rosa26-YFP reporter. After low-density induction at E8.5, we studied the distribution 
of YFP + cells at E16.5. YFP + AMCs were found together with SMCs and ECs in the 
great arteries. About 80% of isl1-mER-Cre-mER hearts at E14.5 exhibited positive cells 
in the mesothelium of the great arteries (Fig. 8E).  The ventricular epicardium as well as 
the proepicardium of the embryos analysed, at E14.5 and E9.5 respectively, were devoid 
of Lineage + cells (Fig. 8E).  Smooth muscle cells and cardiomyocytes of the pulmonary 
trunk are derivatives of the pSHF (Bertrand et al., 2011; Rana et al., 2014; Waldo et al., 
2005). Since AMCs are found together with those cells, they might as well derive from 
posterior SHF progenitors. To test this hypothesis, we traced the fate of late isl1+ 
progenitors (Fig. S3A,B). We found that embryos induced at E9 more consistently 
recapitulated AMC and AMC-related cells labelling than induction at E8.5. The use of the 
Hoxb1-Cre line that targets pSHF progenitors also resulted in the labelling of AMCs (Fig. 
S3C).  
Altogether, these data show that AMCs originate from SHF-related lineages. 
Nonetheless It is still unclear whether in vivo SHF progenitors are multipotent or, 
alternatively, whether heterogeneous progenitors give rise to distinct cell populations in 
the heart and OFT. Heterogeneous AMC clusters found using isl1-mER-Cre-mER lineage 
tracing suggest that AMCs could be related to the cells of the great arteries (Fig. 8E). In a 
second phase, we thus studied OFT randomly generated clones, to explore the possible 
lineage relationships between AMCs and other SHF-derived cells in the arterial pole.   
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Figure 8. Arterial mesothelial cells derive from Second heart field-related progenitors  
(A-B) Mef2c-AHF-Cre lineage tracing. (A) Heart section showing OFT Tom + cells at E14.5. 
AMCs and epicardial cells can be distinguished in green (Wt1). (A’) high magnification of the 
boxed area in A showing the presence of Tom + AMCs (white arrowheads) and Tom - epicardial 
cells (Black arrowhead). (B) Graph representing the number of individuals containing lineage + 
cells in the tissues indicated on the x-axis. (C) Lineage tracing of isl1-Cre embryos at E16.5. 
Maximum Z projection of the OFT. (C’) Optical section of heart in C, the dashed line follows the 
path of the sub-epicardium and sub-mesothelium. The presence of Tom+ AMCs (white 
arrowheads) and Tom- epicardial cells (Black arrowheads) can be appreciated.  (D-E) isl1-mEr-
Cre-Mer lineage tracing of embryos induced at E8.5. (E) Heart section showing YFP+ 
AMCs(arrowheads), SMCs and ECs. (F) Graph representing the number of individuals 
containing lineage + cells in the tissues indicated on the x-axis. All scale bars: 100m. Ao: 
Aorta; PA: Pulmonary artery; ProE: Proepicardium; vent: ventricle Ms: Mesothelium (B,E). Calp: 
Calponin (D)  
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4. AMCs are clonally related to vascular cells of the OFT 
 
Analysis of E14.5 hearts with randomly induced clones showed labelled cells in the 
arterial poles. Different cell types could be found such as endothelial cells (ECs), 
fibroblasts (Fb), Smooth muscle cells (SMCs), AMCs, valvular mesenchymal cells (valv) 
and cardiomyocytes. We focused on clusters containing AMCs and investigated whether 
they contained other cell types as well. Interestingly all AMCs clones also contained cells 
in the inner layers of the Pulmonary artery (PA) and Aorta (Ao). To determine whether 
these clusters arose from independent events of recombination or rather from the 
recombination of multipotent progenitors, we used statistical analysis. We classified 
labelled cell clusters by their composition of cell types and by their proximity to the heart 
(Fig. 9, S4). Using Fisher’s contingency test, we found that AMCs are clonally related to 
cells of the great arteries labelled cell clusters by their composition of cell types and by 
their proximity to the heart (Fig. 9, S4). The first category extends over the distal part of 
the great arteries (Fig. 9A Blue cells), while the second category is located in the proximal 
portion of the pulmonary artery (Fig. 9A Yellow and pink cells). The identification of cell 
types in both categories by immunohistochemistry revealed that distal clones contained 
ECs, SMCs, Fb and AMCs (Fig. 9C-C’’2). In contrast, proximal clones contained AMCs 
(Fig. 9B, D’’1, D’’2, E’’2), SMCs (Fig. 9B, D’’1, D’’2), CM and valvular mesenchymal cells 
(Fig. 9B,D’-E’’2). Proximal clones also contained endothelial-like labelled cells around 
blood cells in the wall of the pulmonary artery in the region adjacent to the ventricle (Fig. 
9A, D’’1, D’’2). Such cells organise as tubes in close proximity to the AMCs. Because of 
their morphology and localisation, they will be referred to as coronary vascular cells 
(CVC). In addition to the presence of AMCs, the majority of proximal clones in the 
pulmonary artery (10 out of 13 groups) showed disperse epicardial cells extending over 
the myocardium at the base of the PA (Fig. 9E’’3). Nonetheless, these cells are not 
comparable to proepicardial-derived epicardial cells because they are scarce and do not 
expand over the ventricle. These results agree with the observed leakiness of the border 
between AMC and epicardial cells. This border is “hermetic” to Proepicardial-derived 
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epicardial cells (cf Fig. 7D) but allows arterial clones to migrate towards the ventricle. 
Since these cells overlie the myocardium, they should be named epicardial cells by 
definition. Since they derive from the SHF, we will name them SHF-derived Epicardial 
Cells (SHF-EpiCs).     
 
Figure 9. AMCs are clonally related to cells of the great arteries 
(A) Scheme of categories of AMC clones and cell types. (B) Description of AMCs clusters per 
cell type. (C-C’’2) Example of YFP + distal clone. (C’’1,C’’2) Sections of the area in C’. YFP + 
ECs and YFP +/SM22 + SMCs can be appreciated. (D-D’’2)Example of a YFP + proximal 
clone. (D’’1,D’’2) Sections of the area in D’. YFP + CVCs are found around erythrocytes (E- E’’3) 
Example of a LacZ + proximal clone (E’’1- E’’3) Sections of area in E’. (E’’1) LacZ+ fibroblasts 
and and endothelial cells. (E’’2) LacZ+ AMCs. (E’’3) LacZ+ SHF-EpiCs.Fb: Fibroblast; 
SM:Smooth muscle; Ms: Mesothelium; valv: valvular cells; CVC: coronary vascular cell; CM: 
Cardiomyocyte; SHF-EpiCs: SHF-derived epicardial cell; EC: Endothelial cell (A,B) All scale 
bars: 100m. Ao: Aorta; PA: Pulmonary artery; RV: Right ventricle; (C-E').  
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All together, these results show that AMCs are clonally related to cells of the great 
arteries, reflecting multipotent properties their progenitors. Furthermore, different lineages 
with different potentialities contribute to the mesothelial layer in this region, with 
proepicardial-derived cells contributing to the ventricle, SHF-derived cells contributing to 
the OFT and base of the arteries and SHF-related splanchnic mesoderm contributing to 
the distal arterial mesothelium.   
On one hand, it was known that SHF progenitors give rise to smooth muscle cells, 
endothelial cells and cardiomyocytes of the arterial pole. However, no link between these 
cells and the AMCs was ever documented. On the other hand, the epicardium is known 
to undergo EMT and provide the heart with the same cell types. We thus wondered if 
AMCs in the distal region of the arteries could have the same properties as their epicardial 
counterparts. Furthermore, we have described a new SHF-derived mesothelial population 
and we wanted to know if they undergo epithelial to mesenchymal transition (EMT) to 
contribute to cells of the inner layers. 
 
5. AMCs give rise to smooth muscle and endothelial cells of the great arteries 
If AMCs are contributing to the great vessels through a mechanism of EMT, they 
should be expressing EMT markers. Known key regulators of EMT are the Snail family 
genes (Alberga et al., 1991; Carver et al., 2001) also essential to the formation of 
epicardial derived cells (EPDCs) (Martínez-Estrada et al., 2010). We first sought to check 
the presence of snail transcription factors in the great arteries at E12.5 by in situ 
hybridization (ISH). As a result, snail transcripts were detected in the arterial mesothelium 
(Fig. 10A-A’’ arrowheads) and through the great arteries but seemed absent from the 
adjacent myocardium (Fig. 10A-A’’). The expression of Snail gene in AMCs suggests that 
the EMT pathway is active in these cells and therefore they have the potential to invade 
and contribute to inner layers.  
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To further test this hypothesis and assess the possible contribution of AMCs to cells 
of the great arteries, we performed lineage tracing with the Wt1-CreERT2 line and the 
tomato reporter. We previously showed that AMCs appear in the OFT as early as day 
E10.5 (52A), we thus administered tamoxifen to mice at that stage and studied the 
distribution of tomato+ cells at E14.5. AMCs were successfully labelled at that stage 
(Fig.10 B). Immunofluorescent staining for CD31 (in green) and SM22 (in white) revealed 
the presence of tomato+ endothelial cells and SMCs respectively (Fig. B,B’). Detection of 
the Oestrogen receptor protein (ER) by immunofluorescence at E11, confirmed that Cre 
recombinase is neither expressed in ECs nor in SMCs at the moment of induction (Fig. 
10C,C’). ER was found expressed in the arterial mesothelium and epicardium instead (Fig. 
10C,C’). These data, together with previous clonal analysis in which we showed no cross-
contribution between the arterial and ventricular mesothelial clones, imply that AMCs are 
giving rise to SMCs and endothelial cells in the great arteries.  
We wanted to know if the plastic properties of AMCs are extensive to later 
developmental stages or are taking place at a restricted stage. To address that issue, we 
additionally induced the Wt1-CreERT2 line at E11.5 or E12.5 and studied the distribution 
of Tom + cells in the great arteries at E14.5 (Fig. S5C,D). As a result, Tom + SMCs as the 
as Tom + ECs could be found in the Ao and PA (Fig. S5C-D’’). These results reflect plastic 
of continuously providing cells to the Ao and PA during at least 3 days of development. 
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These data suggest that part of the arterial inner layers are generated by EMT from 
a primary mesothelial progenitor state. We next sought to determine if AMC-derived cells 
accounted for an important part of the great arterial inner layers.  
To assess the global extent of AMC contribution, we traced their fate using the 
constitutive Wt1-Cre line (Fig. 10D,D’). After harvesting and sectioning hearts at E14.5, 
we quantified the proportion of Tom +/SM22+ out of the entire smooth muscle population 
(Fig. 10E). We also quantified the proportion of Wt1 lineage endothelial cells, calculating 
the number of Tom +/CD31+ cells out of all CD31+ cells (Fig. 10F). All quantifications 
were done according to cell location along the Ao and PA proximo-distal axes. The 
subdivisions were as follow: “region 1” for the area adjacent to the myocardium, “region 
3” for the area adjacent to the cephalic pericardium and “region 2” in the transition zone 
between both. About 50% of the pulmonary artery SMCs were contributed by the Wt1 
lineage in regions 1 and 2, while the proportion dropped to 25% in region 3. Contribution 
of the Wt1Cre lineage to SMCs in the Aorta was consistently about half of that observed 
in the PA for all sub-regions (Fig. 10E).  Regarding ECs, the contributions oscillated 
between 10-15% for the different regions of the PA and Ao, with the exception of the 
intermediate PA’s region 2, in which the contribution was notably higher; 40% (Fig. 10F). 
Figure 10. AMCs give rise to the smooth muscle and endothelial cells of the great 
arteries 
(A) In situ hybridization of Snail on E12.5 sections showing the presence of positive AMCs 
(arrowheads). (A’) and (A’’) are high magnifications of the dashed and solid boxed areas in A. 
They show the presence of positive AMCs in the Ao and PA (arrowheads). (B-C’) Wt1-CreERT2 
hearts (B) Wt1 progenitors induced at E8.5 shows Tom+ cells in the AMCs, Smooth muscle 
(SM22+) and endothelial cells (CD31 +) of the Ao and PA. (B’) high magnification of the boxed 
area in B. white arrowheads point at ECs while black arrowheads point at SMCs. (C) localisation 
of the ER protein at the time of induction. White arrowhead points at positive AMCs, black 
arrowhead points at positive epicardial cells. (C’) high magnification of boxed area in C. White 
arrowheads point at positive AMCs, the black arrowhead points at positive epicardial cells. (D-
F) Lineage tracing of Wt1-Cre. (D) The great arteries can be divided in 3 regions as shown in 
the Ao with the yellow dashed lines. (D’) High magnification of the boxed area in D.  Example 
of a YFP + proximal clone. White arrowheads point at Tom + ECs (CD31 +), the black 
arrowhead points at Tom + SMCs (SM22+). (E) Quantification of Tom+ SMCs shows higher 
contribution to the PA (F) quantification of Tom+ ECs shows similar contribution between Ao 
and PA to the exception of region 2. All scale bars: 100m. Ao: Aorta; PA: Pulmonary artery 
(A,B,D,E,F). OFT: Outflow Tract (C). R: Region (D) 
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The fact that fewer smooth muscle cells were found in the distal part of the arteries (about 
30% for the PA and 15% for the Ao (Fig. 10D,E) reflects the preferential contribution of 
Cardiac neural crest cells (CNCCs) over SHF cells to the distal OFT. In sum, these results 
provide compelling evidence showing that a substantial part of SHF-related progenitors 
contribute to the OFT and arterial roots through an intermediate state as AMCs, which 
then undergo EMT and contribute to various inner lineages.  
Wt1-CreERT2 lineage tracing recapitulated the formation of distal clones 
(described in the previous chapter) since they are composed of SMCs and ECs. Proximal 
clones, however, were not represented since no cardiomyocytes were observed at the 
base of the PA. It is therefore likely that AMCs do not give rise to cardiomyocytes at the 
base of the PA. The fact that proximal clones could not be recapitulated, suggested their 
non-mesothelial origin which prompted us to study in detail the nature of these proximal 
clones. 
 
6. OFT proximal clones give rise to LECs 
 
As mentioned above, proximal clones arise from the deployment of SHF 
progenitors at the arterial pole. We assumed that proximal clones have not fully 
differentiated and expanded at E14.5, so we decided to study them at later stages. We 
reproduced the clonal analysis experiment inducing RERT mice at the same stage as 
previously (E8.5) but harvesting embryos half a day later at E15. In order to analyse the 
clones by confocal microscopy, we used the Rosa26-Td-Tomato and Rosa26-GFP 
reporters.  
Out of a total of 240 hearts, three presented OFT proximal mesothelial clones (Fig. 
11A,F’’). These clones (GFP + cells in this example) are composed of AMCs expressing 
the Wt1 protein (Fig. 11B), cardiomyocytes expressing Troponin T (Fig. 11C), valve 
mesenchymal cells, CVCs and sub-epicardial endothelial cells forming a vascular network 
(Fig. 11A). The vascular structures found, express lymphatic endothelial cell (LEC) 
markers. Indeed, GFP + cells express the lymphatics determining gene Prox1 (Fig. 11C,E) 
46 
 
and Lyve1 (Fig. 11B,D,F-F’). As described above, this type of clones includes epicardial 
cells of SHF origin, which we called SHF-EpiCs.  Interestingly, SHF-EpiCs-, unlike their 
immediate neighbours, are negative for Wt1 (Fig. 11F-F’ black arrowhead), suggesting 
they have a different nature than the mesothelial arterial and proepicardial lineages. 
Instead, SHF-EpiCs were positive for the lymphatic-specification gene Prox1 (Fig. 11E 
arrowhead). Altogether, these results unveil the presence of LECs in early proximal 
clones. While the epicardial layer of the OFT contains isolated Prox1 + cells, the sub-
epicardium underlying this area contains LECs structured in an incipient vascular network.  
In the hearts presenting proximal AMC/ LEC clones, no labelled lymphatic cells were 
found in the rest of the heart. Moreover, we were not able to detect other lymphatic clones 
in the collection of hearts at E15. To investigate the evolution of coronary lymphatics in 
proximal AMC clones at the base of the PA, we aimed at investigating lymphatic clones 
even later in development.  
After clonal labelling by TM injection at E8.5, E14.5 hearts with proximal OFT 
clones accounted for 2% of all generated hearts (13 out of 737 hearts) and 3% of hearts 
containing at least one clone (13 out of 420 hearts). Similarly, induced clones analysed in 
E15 hearts accounted for 3 out of 240 specimens. To study clones later during 
development we thus followed two strategies. On one hand, to increase the chance of 
targeting lymphatic clones and study their distribution, we chose to recombine progenitors 
at higher density (0.1mg of tamoxifen). In that instance, RERT embryos were harvested 
at E16.5. On the other hand, we chose to recombine progenitors at lower density (0.05mg 
of tamoxifen) and study clones at birth (p0). In that setting, we were able to analyse bigger 
cell clusters while maintaining the clonality of labelled groups.  
Out of 71 E16.5 hearts, 9 lymphatic clusters were found (Fig.11G,G’; S6D),  6 of 
which extended predominantly in the ventral side of the heart, while the other three 
affected exclusively the dorsal part of the heart (two of them in the same heart) (Fig. S6C, 
D).   However, the pattern of lymphatic clusters was different depending on their location 
in the heart; two main categories could be observed. Four of the nine LEC clusters, located 
in the ventral side of the heart, showed sparse and scattered cells (Fig.11G,G’ S6A,B). 
On the other hand, two ventral LEC clusters and all three dorsal LEC clusters were dense  
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(Fig.11H,H’, S6C,D). Interestingly, sparse ventral clones did not contribute to the dorsal 
part of the heart. The three sparse ventral clones co-localised with AMCs, SMCs, valvular 
cells, in the PA and CMs at the base of the PA. These ventral clones are thus the 
equivalent of the ventral proximal clones found at E15. However, AMCs were mostly found 
in the distal part of the PA (1/4 with proximal and distal AMCs, 3/4 with distal AMCs) 
suggesting that proximal AMCs do not stay at the surface of the PA. Dense ventral clones 
however, showed lymphatic outgrowths reaching the dorsal part of the heart in two 
instances (Fig. S6D). The dense clusters of the dorsal part of the heart however, did not 
show contribution to the ventral part of the heart (Fig.11H,H’’; S6). Interestingly all dorsal 
clones had positive cells in extra-cardiac LECs in the cephalic region of the heart, 
suggesting their connection to the systemic vasculature. These data suggest that the 
origin and dynamics of formation of the cardiac lymphatic vasculature are different in the 
ventral and dorsal parts of the heart (Fig.11H,H’).  Because the tamoxifen dose used in 
this experiment was high, numerous labelled cells of different cell types were found in the 
E16.5 hearts. High labelling density impedes to decipher precisely lineage relationships 
regarding ventral LECs and dorsal LECs (Fig. S6). We thus studied P0 hearts, induced at 
clonal density to challenge the observations made at E16.5. 
The analysis of 130 P0 hearts labelled at low density spotted two very large 
lymphatic clones. One exclusively affecting the ventral part and one exclusively affecting 
the dorsal part of the heart. As previously observed in E16.5 clones, the dorsal lymphatic 
clone was dense and widely spread over the dorsal aspect of the heart (Fig.11L-L’). Unlike 
the dorsal clone, the ventral clone was composed of scattered cells. Tom + cells were 
mixed with clonally unrelated cells of the ventral lymphatic vascular tree (Fig.11I-K). 
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The heterogeneous pattern of lymphatic clones observed in this study, suggests 
the existence of different sources of LEC progenitors. The lymphatic vasculature had been 
shown to come from the specification of a subset of progenitors in the cardinal vein around 
E9.75 (Yang et al., 2012). Klotz and colleagues shown that not all cardiac LECs derive 
from the cardinal vein (Klotz et al., 2015). They suggested a complementary contribution 
from progenitors of the haemogenic endothelium in the yolk sac. Since we saw different 
patterns and limited cross-contribution between cardiac lymphatic clones of the ventral 
and dorsal parts of the heart, we hypothesised that both aspects of the heart may be 
colonized by different sources of progenitors. We hypothesised that the majority of dorsal 
lymphatic cells is coming from the cardinal vein dorsal clones are composed of extra-
cardiac LECs as well as intra-cardiac LECs (Fig.11H,H’; Fig S5). Moreover, podoplanin 
staining in dorsal clones showed higher intensity level in Tom + extra-cardiac LECs than 
in Tom + cardiac LECs suggesting that they sprout from extra-cardiac vessels (Fig S5). 
In contrast, we assumed that a portion of ventral lymphatic clones must derive from an 
alternative source. Because LECs appeared associated to the SHF-EpiCs between E14.5 
and E15 in proximal clones derived from the SHF, we hypothesized they might form by a 
process of vasculogenesis from SHF precursors in that time window. To challenge the 
idea of a heterogeneous origin for ventral versus dorsal cardiac lymphatic vessels, we 
decided to specifically trace the origin of lymphatic progenitors. 
Figure 11. Proximal AMC clones form lymphatic vessels during late development  
(A-F’) Clone at E15.(A) Z-projection of a GFP+ clone. The arrowhead points at proximal AMCs. 
(B-F’’) are sections of the PA (B) shows GFP+ LECs (Lyve1 +) and AMCs (Wt1 +). (C) shows 
GFP+ LECs (Prox1 +) and Cardiomyocytes (TropT + arrowhead). (D) shows GFP+ LECs 
(Lyve1 +). (E) shows GFP + SHF-EpiCs (Prox1 +). (F-F’’) Area specified with an asterisk in A. 
They show the presence of GFP + Wt1- epicardial cells (black arrowhead) and GFP + sub-
epicardial LECs (Lyve1 + white arrowheads). (G-G’) Ventral GFP + LEC Clone at E16.5. (G) 
Maximal Z-projection of the entire ventral surface. (G’) Z projection of 5 optical sections from 
the asterisk area in G. GFP + LECs are intermingled with GFP – LECs. (H-H’) Dorsal GFP + 
LEC Clone at E16.5. (H) Maximal Z-projection of the entire dorsal surface. (H) high 
magnification of extracardiac GFP + LECs of the dashed box area in H. (H’) high magnification 
of GFP + LECs of the solid box area in H. GFP+ cells are cohesive. (I-K) Ventral tom + P0 
clone. (J) Tom + LECs ( Lyve1 +). (K) Confocal Z- projection of the asterisk area in I. Cells are 
distributed on the ventricle (L,L’) Dorsal Tom+ LEC P0 clone. LECs Tom + cells form an 
organised plexus. (L’) confocal Z- projection of the cross area in L. Tom + cells are cohesive. 
All scale bars: 100m. Ao: Aorta; PA: Pulmonary artery (A). 
 
 
 
50 
 
7. Lymphatic endothelial cells of the ventral and dorsal parts of the heart arise 
from distinct sources of progenitors 
 
To investigate the degree of specification of cardiac lymphatic progenitors at 
different developmental stages, we used the VEGFR3-CreERT2 line, that targets all 
committed and differentiated LECs (Martinez-Corral et al., 2016). The fate of VEGFR3+ 
progenitors was traced with the Rosa26-mTmG reporter, so that every recombined cell is 
expressing the membrane GFP protein, (the un-recombined ones remain Tomato 
positive). Lymphatic progenitors specify and start expressing VEGFR3 around E10.5-
E11.5 in the cardinal vein of mouse embryos (Yang et al., 2012). We thus induced hearts 
at E11.5, when cells start sprouting from cardinal vein-derived lymph sacs (LS). Since the 
peak of recombination takes place about 12 hours after TM administration (Hayashi and 
McMahon, 2002), harvesting hearts only 24 hours after induction is a valuable approach 
to map the location of recently recombined cells as well as to assess the rate of 
recombination. Therefore, embryos were first harvested at E12.5, to verify that 
recombination occurred in the cardinal vein (CV) and lymph sacs (LS). Since VEGFR3 is 
expressed in blood vessels at early stages (Martinez-Corral et al., 2016), we expected the 
recombination of some  blood endothelial cells (BECs).As expected, GFP + cells were 
found in the cardinal vein, inter-somitic vessels (ISVs) and LS (Fig. 12C). Some GFP + 
cells in both the ventral and dorsal parts of the heart did not express Prox1, reflecting their 
possible blood endothelial nature (Fig. 12B,B’’). Interestingly, some embryos exhibited 
GFP + cells in extra-cardiac lymphatics of the cephalic part of the heart both ventrally (Fig. 
12A,A’) and dorsally (Fig. 12B,B’).  After studying the pattern of recombination of 
VEGFR3+ progenitors a day after induction, we decided to study it at E17.5, when an 
established cardiac lymphatic vasculature is present. We reasoned that in the case all 
lymphatics of the heart derive by angiogenesis from pre-specified LECs, there should not 
be any difference in the proportion of VEGFR3-lineage+ LECs between the ventral and 
dorsal part of the heart. If, however, the ventral part of the heart depends on another 
source of progenitors that specifies later during development, there should be less 
VEGFR3-lineage +GFP + LECS in the ventral part than in the dorsal part of the heart. 
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Hearts were systematically stained for prox1 (red) and Lyve1 (blue) for the 
identification of LECs (Fig. 12 D-E’). Overall, less than half of Prox1+/Lyve1 + cardiac cells 
were GFP+ at E17.5 (Fig. 12), which agrees with the incomplete recombination of LECs 
observed at E12.5. We then measured the proportion of GFP + cells in the ventral and 
dorsal parts of the heart, calculating the ratio of Prox1 +/GFP + cells by all prox 1+/Lyve1 
+ cells (Fig. 12). GFP + cells of the dorsal part accounted for about 35% of all Prox1 
+/Lyve1 + cells (Fig. 12E,E’,G,G’).  However, GFP + cells of the ventral part of the heart 
represented only 23% of ventral LECs (Fig. 12A,A’,C,C’,E). The proportion of GFP + cells 
of extra-cardiac lymphatic vessels should reflect the efficiency of recombination of early 
VEGFR3+ progenitors deriving from the CV. We thus quantified the proportion of GFP + 
cells in extra-cardiac LECs in lymphatic vessels of the vicinity of the jugular veins GFP +. 
The proportion of GFP + cells in extra-cardiac LECs, was found comparable to that of the 
dorsal part of the heart. Nevertheless, the proportion of GFP + cells in the ventral part was 
found significantly lower than that of extra-cardiac LECs. Consistently, the proportion of 
GFP + cells of the ventral part of the heart was found to be significantly lower than that of 
the dorsal part of the heart. These data suggest that while dorsal LECs mostly derive from 
the CV, part of the ventral lymphatic vasculature depends on another source. In turn, the 
presence of GFP + LECs in the ventral part of E17.5 embryos (Fig. 12D,D’,F,F’) as well 
as in extra-cardiac LECs of the cephalic part of the heart at E12.5 (Fig. 12A,A’) indicates 
that part of ventral LECs also derive from pre-specified LECs, presumably from the CV.  
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Figure 12. E11.5 VEGFR3+ progenitors give rise to only part of the cardiac lymphatic 
vasculature 
VEGFR3-CreERT2 lineage tracing of embryos induced at E11.5. (A-C) Z projections of 
embryos harvested at E12.5. (A) Ventral view. (A’) High magnification of boxed area in A 
showing extra-cardiac LECs (arrowheads). (B) Dorsal view. (B’) High magnification of solid 
boxed area in B showing GFP + extra-cardiac LECs (arrowheads). (B’’) High magnification of 
dashed boxed area in B showing GFP + BECs (arrowheads). (C) Remote area showing GFP 
+ cells in the Jugular vein and lymph sacs (arrowheads). (D-H) Z projections of embryos 
harvested at E17.5. (D) Ventral view (D’) High magnification of boxed area in D. (E) Dorsal 
view (E’) High magnification of boxed area in E. (F) and (G) are maps of the boxed area in D 
and E respectively where the proportions of GFP + LECs (green) and GFP – LECS (red) can 
be appreciated. Similarly (F’) and (G’) are maps of the boxed area in D’ and E’ respectively. 
(H) Quantification of GFP+ LECs/ all LECs showing higher recombination in dorsal lymphatics. 
All scale bars: 100um. OFT: Outflow Tract (A).RV; Right ventricle; LA: Left atrium; RA: Right 
atrium; LV: Left ventricle (A,B). JV: Jugular Vein; LS: Lymph sacs 
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We next labelled VEGFR3+ cells at different stages to gauge the onset of full LEC 
specification for ventral lymphatics. We followed the same strategy as before, but inducing 
at E12.5, followed by harvesting embryos at E13.5 to determine the sites of recombination 
and at E17.5 to determine the proportions of GFP + LECs in the established lymphatics. 
As previously, E13.5 embryos exhibited GFP + cells in Prox1 + LECs (Fig 13A-C’) and 
Prox1 -BECs (Fig 13A,C’). Similarly, some embryos exhibited extra-cardiac GFP + LECs 
in the cephalic region of the ventral part of the heart (Fig. 13A,A’). Some GFP+ LECs 
however, could be found on the pulmonary artery (Fig. 13A,A’ Black arrow).  In the dorsal 
part, however, LECS appeared arranged in a vascular lymphatic plexus connected to 
extra- cardiac lymphatic vessels (Fig. 13B). In another embryo (less advanced in 
development), we could appreciate extra-cardiac GFP + LECs growing towards the dorsal 
atrioventricular groove (Fig. 12C,C’). These data illustrate, the direct early contribution of 
pre-specified LECs, presumably from the cardinal vein, to the lymphatics of the dorsal part 
of the heart. Direct connection between the cardinal vein and to GFP + LECs in the ventral 
part, was not clear because of tissue orientation.  
Foetuses labelled at E12.5 and studied at E17.5 showed a higher proportion of 
GFP + lymphatic cells GFP + (about 48-67%) (Fig. 13D-G’’) than those induced at E11.5 
(23-35%) (Fig 12H). If, as hypothesised previously, the alternative ventral LECs are not 
fully specified at E13, the gap between the proportions of GFP + cells of the ventral and 
dorsal parts should remain. Indeed, Prox1 +/GFP + cells represented about 48% of all 
Prox1 +/Lyve1 + cells of the ventral part of the heart. In the dorsal part of the heart, 
however, Prox1 +/GFP + LECs proportion remained significantly higher (67%) at this 
stage. Consistently, the proportion of GFP + cells in extra-cardiac LECs was similar to 
that of cardiac dorsal LECs but significantly higher than that of ventral LECs.  
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Figure 13. Cardinal vein VEGFR3 + lymphatic progenitors contribute only partially to 
LECs of the ventral part of the heart. 
VEGFR3-CreERT2 lineage tracing of embryos induced at E12.5. (A-C’) Z projections of 
embryos harvested at E13.5. (A) Ventral view. (A’) High magnification of boxed area in A 
showing GFP + extra-cardiac LECs (arrowheads) and GFP + LECs on the PA. (B) Dorsal view 
showing a lymphatic plexus (Lyve1 +) connected to the extra-cardiac lymphatic vasculature 
(arrowheads). (C) Dorsal view of another embryonic heart (C’) High magnification of solid boxed 
area in C showing extra-cardiac GFP + LECs migrating towards the atrioventricular groove 
(arrowheads). (D-H) Z projections of embryos harvested at E17.5. (D) Ventral view (D’) High 
magnification of boxed area in D. (E) Dorsal view (E’) High magnification of boxed area in E. 
(F) and (G) are maps of the boxed area in D and E respectively where the proportions of GFP 
+ LECs (green) and GFP – LECS (red) can be appreciated. Similarly (F’) and (G’) are maps of 
the boxed area in D’ and E’ respectively. (H) Quantification of GFP+ LECs/ all LECs showing 
higher recombination in dorsal lymphatics. All scale bars: 100um. RV; Right ventricle; LA: Left 
atrium; RA: Right atrium; LV: Left ventricle (A,C).  
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We then sought to determine whether and when the contribution to ventral and 
dorsal LECs by VEGFR3+ progenitors matches.  Embryos were induced with tamoxifen 
at E14.5 and harvested either at E15.5 or E17.5. Interestingly, E15.5 hearts displayed 
similar proportions of ventral and dorsal GFP + LECs (Fig. 14A-E). This means that by 
E14.5 both the progenitors of the ventral and dorsal parts of the heart are present. To 
confirm these observations, we studied the distribution of GFP + cells in E17.5 hearts. As 
expected, not only were the proportions of GFP + cells similar between both parts of the 
heart, but also they were maintained between E15.5 and E17.5 (Fig. 14J,K). Further 
quantification of extra-cardiac Lymphatic vessels, showed that the proportions of GFP + 
cells observed in the heart reflect the efficiency of recombination in extra-cardiac 
lymphatics.   
Our results show different dynamics of cardiac LEC progenitor specification in 
dorsal and ventral regions of the heart.  While full specification of dorsal heart lymphatics 
takes place between E12 and E13, the specification of ventral lymphatics lags behind this 
schedule and is only complete by E15. Together with the observed pattern of lymphatic 
vessel colonization of the dorsal and ventral parts of the heart, these results are 
compatible with the idea that early specified LECs, presumably from the cardinal vein, 
give rise to all dorsal LECs through angiogenesis but only to part of the ventral LECs. 
Figure 14. All VEGFR3 + lymphatic progenitors of the ventral part of the heart are 
specified by E15.5 
(A-B’) Z projections of embryos harvested at E15.5. (A) Ventral view (A’) High magnification of 
boxed area in A. (B) Dorsal view (B’) High magnification of boxed area in B. (C) and (D) are 
maps of the boxed area in D and E respectively where the proportions of GFP + LECs (green) 
and GFP – LECS (red) can be appreciated. Similarly (C’) and (D’) are maps of the boxed area 
in A’ and B’ respectively. (E) Quantification of GFP+ LECs/ all LECs showing equal contribution 
of VEGFR3 + to both parts of the heart. (F-G’) Z projections of embryos harvested at E17.5. 
(F) Ventral view (F’) High magnification of boxed area in A. (G) Dorsal view (G’) High 
magnification of boxed area in B. (H) and (I) are maps of the boxed area in F and G respectively 
where the proportions of GFP + LECs (green) and GFP – LECS (red) can be appreciated. 
Similarly (H’) and (I’) are maps of the boxed area in F’ and G’ respectively. (J) Quantification of 
GFP+ LECs/ all LECs showing equal contribution of VEGFR3 + to both parts of the heart. (K) 
Evolution of the ratio of ventral GFP + LECs/ dorsal GFP + LECs at the different moments of 
induction. All scale bars: 100um. RV; Right ventricle; LA: Left atrium; RA: Right atrium; LV: Left 
ventricle (A,C). 
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Instead, a substantial amount of ventral LECs depends on the contribution of another 
source of progenitors which are not fully specified until E15. The fact that dorsal LECs are 
not fully recombined is mostly a consequence of the incomplete efficiency of 
recombination. Even so, we found an increase in VEGFR3+ progenitors between E12 and 
E13, so we cannot rule out the specification of CV-independent VEGFR3+ progenitors 
between E12 and E13 and their later addition into the heart. Furthermore, these results 
do not exclude, the existence of other complementary cLEC progenitors, such as those 
reported by Linda Klotz and colleagues (Klotz et al., 2015), with a recombination efficiency 
similar to that of CV-derived precursors. These results support the existence of an 
alternative late-specified source for cardiac lymphatic endothelial cells contributing to the 
ventral part of the heart. Because AMCs derive from the SHF, and were found to be 
clonally related to a population of ventral LECs, we reasoned that this late specified 
population may correspond with the SHF-derived LECs. 
 
8. The second heart field contributes to the ventral but not to the dorsal lymphatic 
vasculature 
 
We sought to challenge the possible contribution of SHF progenitors to the 
lymphatic vasculature using a variety of Cre lines recombining the SHF. The first line we 
used was the isl1-Cre line combined with the Rosa26-Tdtomato reporter. Embryos were 
harvested at E17.5 in order to directly compare isl1-Cre hearts to VEGFR3-Cre hearts 
from the previous experiment. Hearts were immuno-stained in whole mount for Prox1 and 
Lyve1 markers. The ventral and dorsal surfaces of the hearts were acquired in 3D using 
confocal microscopy. As predicted by our previous results, Tom + cells were found in the 
lymphatic plexus of the ventral part of the heart (Fig. 15A-A’2). Strikingly, no tomato LECs 
were detected in the dorsal part of the same hearts (Fig. 14B-B’2). The quantification of 
Prox1 +/Lyve1 +/ Tom + cells showed that about 55% of all ventral LECs were labelled 
(Fig. 15C). However, no LEC was found to express the tomato reporter in the dorsal part 
of the heart (0 out of an average of 1341 cells per heart).  
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To corroborate these results, we used the Mef2c-AHF-Cre line, which labels the 
anterior heart field, combined with the Rosa26-YFP reporter. YFP+ LECs were studied on 
sections of E16.5 embryos. The presence of YFP +/Lyve1 +/CD31 + cells in the sub-
epicardium of Mef2c hearts confirmed that SHF progenitors indeed contribute to ventral 
cardiac LECs (Fig. 15D-D’3 black arrowheads). The presence of proximal AMCs (Fig. 15D-
D’3 white arrowheads). as well as SHF-EpiCs expressing Lyve1 and CD31 (Fig. 15D-D’3 
black arrow) could be appreciated in these specimens. 
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To further validate these observations at lower recombination density, we used the 
inducible isl1-mER-Cre-mER mouse line with the Td-tomato reporter. In order to verify 
that posterior SHF progenitors are responsible for the development of ventral LECs, 
embryos were induced at E9 and harvested at E16.5. About 30% of the hearts analysed 
presented sparse tomato cells extending from the base of the pulmonary artery to the 
ventricle (Fig. 15E). Further immunofluorescence experiments on sections, showed that 
Tom + cells were positive for the pan-endothelial marker CD31 (Fig. 15E’1) as well as the 
LEC marker Lyve1 (Fig. 15E’2) and Prox1 (Fig. 15E’3) confirming their LEC nature. 
Consistent with the SHF-origin deduced from the random clonal analysis study, Tom + 
cells include SMCs, valvular mesenchymal cells, Fbs, ECs, CMs and AMCs (Fig. 15E’3). 
Surprisingly, the majority of hearts displaying Tom + LECs did not contain proximal AMCs, 
while previous results showed their presence in E15 clones.  These observations 
suggested a possible incorporation to the pulmonary artery or reconversion of AMCs into 
LECs between E15.5 and E16.5. In order to address the possible reconversion of proximal 
AMCs to a lymphatic fate we used the Wt1-Cre mouse line with the mTmG reporter. 
Hearts were harvested at E16.5 and co-stained for Prox1 and Lyve1. However, no GFP 
+ LECs could be observed (Fig. 15F,F’) indicating that WT1-expressing proximal AMCs 
do not give rise to LECs. 
Figure 15. The SHF gives rise to cardiac LECs but not to dorsal LECs 
(A-C) Isl1-Cre lineage tracing. Z projections of embryos harvested at E17.5. (A) Ventral view. 
(A’1) High magnification of ventral Tom + dorsal LECs. (A’2) map of area in A’1. Red points are 
Tom + LECs and blue points Tom - LECs (B) Dorsal view (B’1) High magnification of dorsal 
Tom – dorsal LECs. (B’2) map of area in B’1. (C) Proportions of Tom+ LECs/ all LECs in the 
ventral and dorsal parts of the heart showing that no LECs from the isl1 lineage form in the 
dorsal part. (D-D’3) Mef2c-AHF-Cre lineage tracing. Sections of embryos harvested at E16.5. 
(D’1-D’3) High magnification of the boxed area in D showing YFP+ proximal AMCs (white 
arrowheads), sub-epicardial LECs ( Lyve1 +/CD31+ black arrowhead) and SHF-EpiCs ( Lyve1 
+/CD31+ black arrow). (E-E’3) Ils1-mER-Cre-Mer lineage tracing of embryos induced at E9 and 
harvested at E16.5. (E) Whole mount Z projection of the Arterial pole area. The volume is 
visualised in the Brightfield. Sparse Tom+ cells are present in the ventricle. (E-E’3) heart 
sections of the area near the asterisk in E show that these cells are LECs (CD31 +, Lyve1 +, 
Prox1+). (F-F’) Wt1-Cre lineage tracing of heart sections at E16.5. (F) Section of the base of 
the pulmonary artery. (F’) High magnification of the boxed area in F showing that LECs are not 
GFP +. All scale bars: 100 m. Ao: Aorta; PA: Pulmonary artery; RV: Right ventricle; LV: Left 
ventricle; RA: Right atrium; (A,E’3). 
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Altogether, these results identify the SHF as an additional source to CV-derived 
lymphatics for cLECs in the ventral part of the heart.  
 
9. The lymphatic vasculature of Tbx1 null-mice is altered in the dorsal part of the 
heart but fails to form in the ventral part of the heart 
 
Tbx1, is essential for SHF deployment and Tbx1 mutants present defects of the 
lymphatic vasculature (Chen et al., 2010). We thus sought to understand if Tbx1 mutation 
could cause defects specifically in SHF derived cardiac lymphatic vessels. To investigate 
whether Tbx1 loss of function would cause defects specific to the ventral cardiac lymphatic 
vasculature, we studied the hearts of Tbx1 mutant embryos. Tbx1-/- hearts were 
harvested at E16.5, sectioned and stained by immunofluorescence for Lyve1, Prox1 and 
CD31 proteins (Fig. 16C-D’’). WT littermates followed the same procedure and were used 
as controls (Fig. 16A-B’’). As described in the literature, the hearts of Tbx1 mutants 
presented a common arterial trunk (CAT). The study of the three markers, identified extra-
cardiac lymphatics located cranially to both the ventral and dorsal parts of the heart 
(Fig.16A,A’,B,B’,C,C’,D,D’). The presence and distribution of these extra-cardiac vessels 
was similar in mutant and WT hearts (Fig.16A,A’,B,B’,C,C’,D,D’).   In the dorsal part of 
Tbx1-/- hearts, we observed lymphatic vessels that seemed slightly less developed than 
in the dorsal part of WT hearts (Fig. 16B-B’’,D-D’’, E). The number of Prox1 +/CD31 + 
cells in the dorsal part of Tbx1-/- hearts also seemed to be smaller, indicating a reduced 
cellularity of mutant lymphatic vessels (Fig. 16F), however, these observations were not 
found to be statistically significant. While the ventral part of WT hearts was covered of 
lymphatic vessels, in contrast, the ventral part of Tbx1 mutants displayed more severe 
defects than the dorsal part. Even though numerous Lyve1 + cells were observed (green) 
in the ventral part of Tbx1-/- hearts, none co-localized with CD31 and Prox1 markers (Fig. 
15A,A’’1, A’’2 arrowheads).  The morphology of these Lyve1 + cells indicates that they are 
most likely Lyve1 + macrophages (Maruyama et al., 2005; Schledzewski et al., 2006).  
The ventral surface of Tbx1-/- hearts was therefore completely devoid of LECs (Fig. 
16E,F). The CAT of one of four mutant embryos presented immature lymphatic vessel 
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structures in the wall of the CAT  which suggests that LECs form but fail to expand towards 
the ventricle. These results show that the cardiac lymphatic vasculature of Tbx1 mutants 
is more severely altered in the ventral part of the heart than in the dorsal part of the heart. 
Given the role of Tbx1 in deploying SHF progenitors at the arterial pole of the heart, these 
results support the involvement of the SHF in ventral cardiac lymphatic development. 
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Figure 16. Tbx1-/- hearts exhibit more severe ventral lymphatic defects than dorsal 
lymphatic defects 
(A-B’) Sections of WT hearts. (A) Ventral view. (A’) high magnification of solid boxed area in A 
showing extra-cardiac LECs (Prox 1 +; Lyve1 +). (A’’) high magnification of dashed boxed area 
in A showing cardiac LECs. (B) Dorsal view. (B’) high magnification of solid boxed area in B 
showing extra-cardiac LECs. (B’’) high magnification of dashed boxed area in A showing 
cardiac LECs. (C-D’’) Sections of Tbx1-/- hearts. (C) Ventral view. (C’) high magnification of 
solid boxed area in B showing extra-cardiac LECs (Prox 1 +; Lyve1 +). (C’’1) and (C’’2) are 
high magnification of dashed box in C, showing that Lyve1 + cells (arrowheads) are not LECs 
(CD31-). (D) Dorsal view. (D’) high magnification of solid boxed area in D showing extra-
cardiac LECs. (D’’) high magnification of dashed boxed area in D showing cardiac LECs. (E) 
LEC number/ section. No Lymphatic vessels were found in the ventral part of Tbx1-/- embryos. 
(F) LEC number/ section. No LECs were found in the ventral part of Tbx1-/- embryos. All scale 
bars: 100 m. 
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11. The Pulmonary artery contains a lymphvasculogenic niche of progenitors  
 
These results together with data from the previous experiments suggest that SHF 
progenitors recruited to the mesothelial/sub-mesothelial region of the base of the PA. 
These progenitors might then become specified and LECs contribute to 
lymphangiogenesis in the ventral side of the heart. We next sought to address this 
hypothesis.  To test this hypothesis and confirm the nature of lymphatic progenitors in this 
area, we performed tissue grafting and tissue culture techniques. We used E14.5 Wt1-
Cre; Rosa26-mTmG hearts as fluorescent tissue donors and the hearts of their WT 
littermates as recipients (Fig. 17A). In these donor hearts, the mesothelial layer is GFP +, 
while the sub-mesothelial layer is Tom +. Portions of the mesothelial/sub-mesothelial 
layers of the proximal PA from donor hearts were peeled off. They were then transplanted 
onto the hearts of WT littermates in the area of the ventricle where the first ventricular 
lymphatic vessels are observed at E15.5 (ventricle portion under the base of the PA) (Fig. 
17A,B). As a control, the epicardium and sub-epicardium of fluorescent donors was 
dissected from the same area and transplanted onto WT hearts (Fig. 17A,D). 
Transplanted hearts were then placed in culture for three days. In the donor tissue, un-
recombined sub-mesothelial cells stay Tom + while recombined mesothelial cells are GFP 
+ (Fig. 17A). It is thus possible to distinguish the fate of AMCs and epicardial cells (EpiCs), 
both GFP +, from the fate of sub-AMCs and sub-epicardial cells respectively, both Tom +. 
The heart sections of control transplants exhibited in most cases an “epicardial-like” layer 
made of GFP + cells continuous with the recipient’s epicardium (Fig. 17E,E’ white 
arrowheads, G).  PA transplants, in contrast, showed much fewer cells staying on the 
outer surface of the heart (Fig. 17C,C’ dashed line G), indicating an increased invasive 
activity of AMCs with respect to EpiCs. Cells deriving from the Wt1 lineage (GFP +) 
predominate among those invading the myocardium in the case of epicardial orthotopic 
transplants (Fig. 17E,E’,G) while PA transplants showed a similar proportion of invading 
cells from the Wt1+ lineage (GFP +) and from the sub-mesothelium (Tom +).  We 
performed an immunofluorescence staining for the lymphatic marker prox1 in order to 
assess the presence of lymphatic cells derived from the transplant. In epicardial 
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transplants we did not find any Prox1 + cell derived from either GFP + or Tom + cell (Fig. 
17C,E,E’,F), however Prox1 + cells could be found in sub-epicardial cells of the host heart 
(Fig. 17E black arrowhead).  In PA transplants GFP + cells of mesothelial origin did not 
contribute to Prox1 + cells, in contrast, the Tom + cells of sub-mesothelial origin organised 
into vascular tubes that expressed Prox1 (Fig. 17C,C’ arrowheads, F). Occasionally, Tom 
+ cells were seen in the epicardial layer.  This observation agrees with the fact that in the 
clonal analysis some Prox1 +, WT1 - cells related by lineage with the sub-epicardial 
lymphatics appear in the epicardium close to the base of the PA. These results confirm 
that a population of WT1-negative sub-mesothelial cells at the base of the PA have the 
ability to form coronary lymphatic vessels. Equivalent cell populations in the adjacent 
epicardium, however, do not have this ability.   
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12. The mesothelium and sub-mesothelium of the arteries exhibit lower Raldh2 
levels than their ventricular counterparts 
 
Our results suggest that the proximal sub-mesothelium/mesothelium of the PA is a 
vasculogenic niche for the specification of SHF-derived ventral cLEC progenitors. In order 
to understand better the molecular cues that drive lymphatic specification in that region, 
we decided to identify differentially expressed genes between the arterial 
mesothelium/sub-mesothelium and the epicardium/sub-epicardium. 
The mesothelium/ sub-mesothelium of the arteries and the epicardium/sub-epicardium 
of the ventricles of WT hearts was peeled off to study their respective transcriptome by 
RNA sequencing (Fig.18). Interestingly the mesothelium of the arteries presented a 3-fold 
decrease in Raldh2 expression compared to the epicardium of the ventricle (P-value: 
0,0004). These results are similar to what was previously reported in chick embryos 
(Pérez-Pomares et al., 2003). Interestingly, analysis of RNA samples with the ingenuity 
pathway software showed an active network for endothelial cell movement and 
Figure 17. Pulmonary artery sub-mesothelium transplants give rise to lymphatic 
vessels. 
(A) Wt1-Cre; mTmG mouse embryos were harvested at E14.5. Wt1-Cre; mTmG double 
heterozygous embryos were used as donors since they express GFP in the epicardium and 
AMCs. They also express Tomato in the sub-epicardium and the arterial sub-mesothelium. 
Their WT littermates were used as non- fluorescent recipients. The mesothelium of the PA 
(circle, homotypic) or the Epicardium of the ventricles (square, heterotypic) were transplanted 
into the ventricle of recipient hearts, at the base of the PA. (B) Whole mount picture of a heart 
with a heterotypic transplant. (C) and (C’) are sections of the transplanted heart with and without 
the brightfield channel respectively. The dashed line represents the border of the epicardium. 
Tom +, Prox1 + LECs formed vascular tubes (black arrowhead). (D) Whole mount picture of a 
heart with a homotypic transplant. (E) and (E’) are sections of the transplanted heart with and 
without the brightfield channel respectively. The dashed line represents the border of the 
epicardium. (E) Prox1 was expressed in the host tissue but not in the explant (black 
arrowhead). The epicardial cells of the explants form an epicardial layer continuous with the 
host’s epicardium (White arrowheads). (F) Number of Prox1 + cells from the donor. The cells 
of the heterotypic donor formed LECs. (E) Distribution of fluorescent donor cells in the outer 
and inner layers of the heart. Heterotypic donor cells mostly invaded the heart. All scale bars: 
100m. PA: Pulmonary artery; Vent: Ventricle. 
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vasculogenesis in AMCs and sub-AMCs (Fig. 18 A). In addition, analysis of upstream 
regulators showed inhibition of Wt1 gene and activation of the EMT-related gene Twist  
suggesting a loss in epithelial integrity (Fig. 18 B). 
 
Figure 18. AMCs express low levels of Raldh2 compared to the epicardium 
(A) Ingenuity pathway analysis of the regulator networks activated in AMCs as compared to 
epicardial cells of the ventricle. (B) Ingenuity pathway analysis of the upstream regulators 
activated and inhibited in AMCs as compared to epicardial cells of the ventricle. (C-E) All 
images were acquired in the OFT part of the heart at E14.5 (C) E14.5 heart showing the 
myocardium in red and Raldh2 expression in the heart epicardium and arterial mesothelium. 
The arrowheads point at low Raldh2 areas. (D) Mef2c-AHC-Cre used as a reference to identify 
AMCs. Proximal AMCs exhibit low to undetectable Raldh2 levels (arrowheads). (E) LacZ + 
clone from the clonal analysis in which proximal AMCs are Raldh2 negative. All scale bars: 
100m. Ao: Aorta; PA: Pulmonary artery. 
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To confirm the results obtained by RNAseq, we studied Raldh2 expression in the 
OFT at E14.5. MHC-Cre;Tdtomato hearts were used in order to identify the myocardium 
(in red) and were immuno-stained for RALDH2 protein (in green) (Fig.18C). Analysis of 
such hearts in whole mount showed that overall, epicardial cells and AMCs express high 
levels of RALDH2 (green), with the exception of the proximal AMCs (Fig.18C arrowheads), 
which exhibited lower to undetectable levels of RALDH2 (Fig.18C). To corroborate these 
observations, we employed the Mef2c-AHF-Cre; Rosa26-Tdtomato mouse line as a 
reference to distinguish AMCs (Tom +) from the epicardium. Hearts were sectioned and 
immuno-stained for RALDH2 protein at E14.5. As expected, a substantial portion of AMCs 
at the border with the myocardium exhibited low levels of RALDH2 (Fig.18D arrowheads). 
These data prompted us to wonder if proximal AMC clones include cells from the 
RALDH2-low zone. Hearts from the random clonal analysis were thus immuno-stained for 
RALDH2 (in pink) (Fig.18E). AMC cells belonging to clones containing AMCs and sub-
epicardial cells invading the myocardial area were found located in the area with low 
RALDH2 levels (Fig. 18E).  The singular behaviour of this mesothelial niche at the base 
of the PA therefore correlated with the only mesothelial areas of the whole cardiac region 
that do not express RALDH2, raising the possibility that low RA levels condition this niche. 
 
13. RA signalling plays a role in cardiac lymphatic development and maturation 
 
We next investigated whether Retinoic acid (RA) signalling was implicated in the 
specification of lymphatic progenitors. RA signalling has been shown to be essential for 
lymphangiogenesis at early stages (Bowles et al., 2014). In addition, RA is known to be 
important for the maturation and patterning of blood vascular cells (Lai et al., 2003; 
Wang et al., 2018b). We therefore hypothesised that low Raldh2 levels might enable 
specification and expansion of LEC progenitors, while high Raldh2 levels could promote 
angiogenesis and maturation of the lymphatic plexus in the ventricles. 
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To study the role of RA signalling in cardiac lymphatic vessel formation, we used 
embryos in which WT1-Cre drives the recombination of a Raldh2 conditional Knock-Out 
(KO) allele in epicardial cells and AMCs. We sought to compare the state of maturation 
and remodelling of lymphatic vessels in mutant hearts compared to their WT littermates. 
Hearts were harvested at E16.5 and stained by immunofluorescence with Lyve1 and 
Prox1 antibodies. Additional immunofluorescence with Raldh2 antibody showed the total 
absence of RALDH2 protein in the mesothelium of mutant hearts compared to WT hearts 
(Fig S7). Mutant hearts exhibited altered lymphatic vasculature patterns in both ventral 
and dorsal parts of the heart (Fig. 19C-D’) compared to Wild types (Fig. 19C-D). The state 
of maturation and patterning of a vascular plexus can be assessed looking at its degree 
of complexity. We thus analysed phenotypic markers of maturation such as the number 
of vascular branches, branching events and tubes (region in the centre of anastomosed 
branches). In general, the mutant lymphatic tree seemed more immature and with thicker 
vessels (Fig. 19A-B’). The base of the PA in the ventral part (Fig. 19A,C,C’ dashed line) 
and the atrioventricular groove in the dorsal part of the heart (Fig. 19B,D,D’ dashed line) 
were used as a reference to quantify the distances of the cardiac lymphatics. Even though 
KO lymphatic vessels generally reached the same total length as WT lymphatic vessels 
(Fig. 19E), the average distance from the base of the heart to the first lymphatic forks was 
bigger in the mutants (Fig. 19C’,D’, arrows F). This means that at the base of the PA and 
in the dorsal atrio-ventricular groove the lymphatic vasculature of WT hearts splits into 
various branches while mutant lymphatic vessels form extended sac-like structures before 
forming branches (Fig. 19D,D’). This suggests that the lymphatic vasculature of KO hearts 
is less remodelled than that of WT hearts. Consistently, KO hearts formed less lymphatic 
vascular tubes (Fig. 19G) and generated fewer branching events (Fig. 19H) than WT 
hearts. We have thus shown that epicardial RA signalling has an effect on the maturation 
of the cardiac lymphatic plexus. To confirm these observations, we aimed to perform the 
reciprocal experiment by exposing embryonic hearts to an excess of RA. 
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Figure 19. Raldh2 depletion from the cardiac mesothelium prevents the maturation of 
the heart lymphatic vasculature 
(A-B’) Z-projections of WT E16.5 hearts. (A) Ventral view showing the normal vasculature (Prox 
1 +; Lyve1 +). (B) Dorsal view showing the normal dorsal vasculature (Prox 1 +; Lyve1 +). (C-
D) Z-projections of Wt1; R26-Raldh2 f/f mutant embryos. (C) and (D) are the ventral and dorsal 
views of mutant hearts. They exhibit an abnormal lymphatic vasculature. (C’) and (D’) are the 
maps of LECs of the solid boxed area in C and D respectively. The abnormal morphology of 
lymphatic vessels can be appreciated. (A,C,C’) The yellow dashed lines at the base of the heart 
ventrally are used as a reference for measurements. (B,D,D’) The yellow dashed lines in the 
atrioventricular groove dorsally are used as a reference for measurements. (E) Quantification 
of the tip to base distance in WT and mutants. No difference was found. (F)average distance 
from the reference lines to the first forks. Example measurements in (C’) and (D’) (Bi-directional 
yellow arrows). (G) the average number of tubes and (H) branching events was lower in mutant 
embryos. All scale bars: 100 m. RV; Right ventricle; LA: Left atrium; RA: Right atrium; LV: Left 
ventricle (A-D). 
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Since the part of the lymphatic vasculature derived from SHF progenitors is 
specified around E14, we decided to inoculate embryos at E13,5 with 6.75 mg of RA. 
Pregnant mice were either inoculated with RA (Fig. 20A-B’) or sesame oil (controls) (Fig. 
20C-D’) to test two hypotheses. On one hand, we wanted to know if an excess of RA could 
affect the specification or differentiation of SHF-derived lymphatic progenitors at the base 
of the PA. On the other hand, we wanted to determine if an excess of RA could affect the 
ventricular lymphangiogenic process.  Hearts were immuno-stained at E15 in whole 
mount for Lyve1 and Prox1 antibodies. The lymphatic vasculature of RA-treated hearts 
appeared more branched and composed of thinner vessels than that of untreated animals 
with an exacerbated effect on ventral lymphatic vessels (Fig. 20A-D, E). In addition, we 
observed a higher presence of one-cell wide capillaries in the ventral part of the heart (Fig. 
20C-C’1 arrowhead). Treated animals formed more discontinuous vessels and formed 
more branching events than untreated animals (Fig. 20C-C’ arrowheads). In untreated 
embryos, LECs in the great arteries form sac-like vascular structures with large lumens 
and appear poorly remodelled compared to lymphatics in the heart (as described in 
chapter 4) (Fig. 20A-A’2). The LECs of embryos treated with RA formed an organised 
vascular plexus instead (Fig. 20C-C’2).  Indeed, the lymphatic vessels on the PA of treated 
embryos was more branched (Fig. 20H) and presented more tubes as a result. In the 
dorsal part of the heart, the lymphatic vasculature seemed less affected (Fig. 20B-D’). 
However, it presented generally more branches and branching events. Overall, the 
average size of the branches was also smaller than untreated animals (Fig. 20B’-D’). 
Overall, it seems that RA triggers the premature remodelling of the cardiac 
lymphatic vasculature. RA also seems to promote the maturation of cardiac lymphatics 
since the lymphatic sac-like structures in the PA are not maintained in an immature state 
in untreated animals. The exacerbated phenotype in the ventral part of the heart is 
consistent with altered specification of Lymphatic SHF progenitors. 
All together, we have shown that RA signalling is an actor of cardiac 
lymphangiogenesis. It seems that low Raldh2 levels are necessary for the expansion of 
lymphatic progenitors (e.g. dilated lymphatic vessels in the case of Raldh2-/- embryos) 
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while RA signalling is most likely responsible of the maturation and patterning of the 
primary lymphatic vasculature.  
 
As a summary, our results show that the SHF on one hand gives rise to the smooth 
muscle and the endothelium of the great arteries through EMT of distal AMCs. On the 
other hand, the second heart field gives rise to proximal AMCs together with sub-
mesothelial lymphatic progenitors. These lymphatic progenitors in turn, start their 
Figure 20. Excessive RA levels trigger the hyper-remodelling of the cardiac lymphatic 
vasculature 
(A-B’) Z-projections of untreated E15 hearts. A) Ventral view. (A’) high magnification of solid 
boxed area in A showing the normal vasculature (Prox 1 +; Lyve1 +). (A’2) high magnification 
of dashed boxed area in A showing the sac like immature pattern of LECs of the Pulmonary 
artery(B) Dorsal view. (A’) high magnification of boxed area in A showing the normal dorsal 
vasculature (Prox 1 +; Lyve1 +). (C-D’) Z-projections E15 hearts treated with RA. C) Ventral 
view (C’1) high magnification of solid boxed area in C showing an hypoplastic and hyper-
remodelled vasculature. More one-cell wide branches were found (white arrowhead). (C’2) high 
magnification of dashed boxed area in C showing hyper-remodelling and maturation of the PA 
lymphatic vasculature vasculature. (D) Dorsal view (D’) high magnification of boxed area in D 
showing showing thinner vessels (Prox 1 +; Lyve1 +). All scale bars: 100 m. 
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specification and differentiation at a localized vasculogenic niche of low-RALDH2 AMCs 
at the base of the PA. From this region, they migrate into the ventricular sub-epicardium 
and contribute to the ventral cardiac lymphangiogenesis. In parallel, the lymphatic 
vasculature deriving from the CV colonizes the heart surface by angiogenesis and cells 
from both origins intermingle exclusively in the ventral part of the heart. Finally, the 
maturation and patterning of the cardiac lymphatic vasculature is influenced by RA 
signalling cues from the epicardium.  
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Figure S1. Epicardial and AMC clones 
(A) Whole mount ventral view of a heart with YFP+ epicardial clusters. (B) high magnification 
of the OFT area specified with a cross in A. (C) high magnification of the area specified with 
an asterisk in A. (D) Whole mount of the lateral view of a heart with LacZ+ epicardial clusters. 
The arrows point at epicardial clusters (E) high magnification of the area specified with an 
asterisk in D. (F) Graph representing the number of hearts, in the collection, that present 
clusters from a range of 1 to 7. (F and H) Analysis of epicardial and arterial mesothelial cluster’s 
colour and location. Hearts are classified by ID (left column). Brown and blue rectangles 
represent YFP+ and LacZ+ clusters respectively. A rectangle without number is equivalent to 
the presence of only one cluster. The numbers displayed on the rectangles indicates the 
respective number of clusters found in that colour. (H) represents all the hearts with epicardial 
clones but no AMCs in neither the Aorta (Ao) nor the Pulmonary artery (PA). (F) represents all 
the hearts containing AMC clones in the Ao or the PA and whether they contain epicardial 
clones too. Scale bar: 200m (A), 100m (B-E). Ao: Aorta; PA: Pulmonary artery; RA: Right 
atrium; LA: Left atrium; RV: Right ventricle; LV: Left ventricle (A-H). 
 
Figure S2. AMCs develop in the OFT of the heart from E10.5 onwards 
(A-D) Frontal sections of the Ouflow Tract area of WT hearts. The myocardium can be 
appreciated by immunofluorescence for troponin T (green) and mesothelial cells by 
immunofluorescence for Wt1 (red). (A,B) Arrowheads point at arterial mesothelial cells. All 
scale bars: 100m. OFT: Outflow Tract (A,B). Ao: Aorta; PA: Pulmonary artery (C-D). 
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Figure S3. AMCs are derivatives of the posterior SHF 
(A-B) Lineage tracing of early and late isl1+ progenitors. (A) Representative heart induced at 
E8.5 where most labelled cells are localised in the right ventricle (black arrowheads). (B) 
Representative heart induced at E9 where most labelled cells are localised in the great arteries 
and OFT area (black arrowheads). (C) Lineage tracing of Hoxb1+ progenitors with the YFP 
reporter (Green). We can appreciate the presence of YFP +/Wt1 + AMCs in the Aorta as well 
as the pulmonary artery (white arrowheads).  scale bar: 100m. Ao: Aorta; PA: Pulmonary 
artery (C). 
 
Figure S4. AMCs are clonally related to cells of the great arteries 
The table represents the composition of cell clusters in the Aorta (Ao) and Pulmonary artery 
(PA). Each number represents the number of groups observed. The colours refer to the type 
of reporter expressed. This data together with show that arterial mesothelial cells are clonally 
related to cells of the great arteries. 
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Figure S5. AMCs continuously give rise to SMCs and ECs of the great arteries 
(A-D) Wt1-CreERT2 lineage tracing of embryos induced from E9.5 to E12.5 and harvested at 
E14.5. (A’-D’) High magnifications of these hearts in which Tom+ smooth muscle cells (SM22 
+) can be appreciated. (A’’-D’’) High magnifications of these hearts in which Tom+ endothelial 
cells (CD31 +) can be appreciated.  where most labelled cells are localised in the right ventricle 
(black arrowheads). (E-G) Localisation of the inducible Cre recombinase visualised by 
immunofluorescence of the ER protein (Red). ER is expressed in mesothelial cells but not in 
smooth muscle nor endothelial cells. Scale bars: 100m. Ao: Aorta; PA: Pulmonary artery (A-
D). 
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Figure S6. Analysis of lymphatic groups at various stages 
(A-B) Specimens containing fluorescent lymphatic groups generated inducing RERT embryos 
at E8.5 and harvesting hearts at E16.5. (A) Tomato cells sparsely distributed in the ventral part 
of the heart(arrowheads). (B) Identification of Tom+ cells on sections. (C) Tom+ and GFP+ 
dorsal lymphatic clones. Recombined cells are forming a wide and highly organised network. 
Extra-cardiac GFP+ and Tom + lymphatic cells can be observed (arrowheads). (D) Summary 
of lymphatic groups observed in their colour (Tomato: red or GFP: green crosses). The resulting 
count out of all hearts of each category is represented in the second half of the table. Overall 
ventral and dorsal lymphatic groups seem different and mostly arise independently.  LECs : 
Lymphatic endothelial cells, pAMC: proximal Arterial mesothelial cell, dAMC: distal arterial 
mesothelial cell.  
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Figure S7. Raldh2 is successfully depleted in the mesothelium of Wt1-Cre; Raldh2 f/f 
embryos 
(A-B) Z-projections of WT E16.5 hearts. (A-B) Ventral view showing normal vasculature (Prox 
1 +; Lyve1 +) and normal Ralhd2 expression in mesothelial cells. (C-D) Z-projections of Wt1; 
R26-Raldh2 f/f mutant embryos. They exhibit an abnormal lymphatic vasculature and the 
complete lack of RALDH2 protein in the epicardium and AMCs. All scale bars: 100 m. RV; 
Right ventricle; LA: Left atrium; RA: Right atrium; LV: Left ventricle. 
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Material and methods 
 
1.Animal procedures 
 
1.1 Mice strains 
 
Animals were handled in accordance with CNIC Ethics Committee, Spanish laws 
and the EU Directive 2010/63/EU for the use of animals in research. All mouse 
experiments were approved by the CNIC and Universidad Autónoma de Madrid 
Committees for “Ética y Bienestar Animal” and the area of “Protección Animal” of the 
Community of Madrid with reference PROEX 220/15. For this study, Mice were maintained 
on mixed C57Bl/6 or CD1 background. The following mouse lines were used: 
Cre inducible and constitutive mouse lines: 
Polr2a-CreERT2 (RERT) (Guerra et al., 2003) 
Isl1-Cre (Cai et al., 2003) 
Isl1-mER-Cre-mER (Laugwitz et al., 2005) 
Mef2c-AHF-Cre (Verzi et al., 2005) 
Wt1CreERT2 (Zhou et al., 2008) 
Wt1Cre (Wessels et al., 2012) 
Hoxb1IRES-Cre (Arenkiel et al., 2003) 
Vegfr3-CreERT2 (Martinez-Corral et al., 2016) 
 
Enhancer trap and Knock outs: 
Raldh2L-/- (Vermot et al., 2003) 
Tbx1tm1Pa mice (Jerome and Papaioannou, 2001) 
 
Enhancer trap and Reporter lines: 
Mlc1v-nlacZ-24  
(Fgf10-nlacZ enhancer trap) 
(Kelly et al., 2001) 
R26R-LacZ (Soriano, 1999) 
R26R-EYFP (Srinivas et al., 2001) 
R26R-tdTomato (Madisen et al., 2010) 
R26-mTmG (Muzumdar et al., 2007) 
R26-GFP (Sousa et al., 2009) 
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Mice were genotyped by PCR as stated in the original reports.  
 
1.2 Tamoxifen preparation and maternal administration 
 
Tamoxifen for intraperitoneal injection: 
For induction of the RERT line, 10mg of 4-Hydroxy Tamoxifen (Sigma) was 
dissolved in 1ml absolute Ethanol and 9ml corn oil (Sigma) for a final concentration of 
1mg/ml.  The stock solution was then sonicated for 40 minutes on ice to prevent 
overheating. The 4-OHT solution was aliquoted and stored at 4ºC for up to 4 weeks, and 
re-sonicated before being administered to mice.  
Tamoxifen for oral gavage: 
For induction of all the other Cre lines 200mg of Tamoxifen (Sigma) was dissolved 
in 10ml of corn oil (Sigma) for a final concentration of 20mg/ml (to the exception of 
VEGFR3-Cre for which mg of Tamoxifen were diluted in sesame oil).  The stock solution 
was then sonicated for 20 minutes on ice. The solution was aliquoted and stored at RT for 
up to 3 months. Tamoxifen was administered by oral gavage using a 1ml syringe (Beckton 
Dickinson) via a feeding needle (BD Microlance) in a range of 1 to 4 mg/female. 
 
1.3 Maternal administration of Retinoic acid: 
 
RA was administered to pregnant CD1 mice by oral gavage using a 1ml syringe 
and a feeding needle. 6.75 mg of crystalline all-trans RA (302-79-4 Sigma) was diluted in 
0.8 ml of Ethanol (EtOH) in 9.2 ml sesame oil. The solution was sonicated, aliquoted and 
stored in the dark at 4C. Samples were sonicated before being administered to pregnant 
females.  Pregnant mice were administered at E13.5 and E14.5 days of gestation with a 
6.75mg RA dose. Control were administered equivalent volumes of the vehicle (i.e., EtOH 
in sesame oil) at the corresponding times. 
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1.4 Embryo harvest 
 
Embryos were staged defining the morning of the vaginal plug as embryonic day (E) 0.5. 
Females were sacrificed by CO2 inhalation followed by cervical dislocation. Mice embryos 
were extracted at different developmental stages as follow. The abdominal cavity of 
sacrificed females was opened to expose the Uterus. The uterus was then placed in ice-
cold PBS in a petri dish in order to open the muscle layer, decidual layer and amnion. 
Once extracted, embryos were decapitated and their thorax opened at the level of the 
sternum. If the heart needed to be isolated, it was pulled out with forceps. Unless stated 
differently, all tissues were dissected in ice-cold PBS and fixed in PFA (Merck) 2% in PBS 
overnight at 4ºC. 
 
1.5 Neonatal heart harvest 
 
After their birth, P0 (postnatal 0) mice were decapitated. Their thorax was then cut at the 
level of the sternum similarly to embryos and their heart pulled out. Hearts were place in 
ice-cold PBS to remove the lungs and fixed in PFA 2% in PBS overnight at 4ºC. 
 
1.6 Clonal analysis 
 
For retrospective clonal analysis, we used mouse embryos with the inducer Polr2a-
CreERT2 (RERT) and the reporter R26R-lacZ; R26R-YFP knock-in alleles in 
heterozygosis. This genotype was generated upon breeding mice that have the inducer 
and reporter allele in double homozygosis with mice that have the other reporter allele in 
homozygosis. Random Cre-mediated recombination was obtained using 4-hydroxy-
tamoxifen (4OHT) dissolved in corn oil. A single dose of 4OHT (0.1mg, 0.0675mg or 
0.05mg) was injected intraperitoneally into pregnant females at E8.5 days of gestation. 
Recombination triggered either LacZ or YFP expression in single cells and their progeny. 
The hearts of embryos were dissected and analysed at E14.5, E15 and in neonates at P0. 
Upon recombination, cells go through cell division and differentiation giving rise to cell 
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clusters of labelled cells. Out of 737 embryos harvested at E14.5 only 454 showed labelled 
cells because of low 4OHT induction. 
 
1.7 Mouse blood serum preparation 
 
Mouse blood was collected on sacrificed adult WT mice and serum was prepared 
as described previously (Greenfield, 2017). 
 
2.Tissue processing 
 
2.1 In situ hybridisation on Paraffin sections  
 
2.1.1 Paraffin embedding 
 
Upon ON fixation in 4% PFA at 4ºC, embryonic tissues were rinsed several times 
in PBS, and dehydrated through gradual concentrations of EtOH:H2O (30%, 50%, 70%, 
85%, 90%, 96%, 100%) at room temperature. Samples were washed twice in xylol and 
twice in paraffin wax at 65ºC. Embryos were oriented and embedded in warm paraffin and 
left at 4ºC on to solidify. 
 
2.1.2 In situ hybridisation  
 
In situ hybridisation was performed on 7 μm-thick paraffin sections according to 
previously described protocols (Jostarndt K. et al., 1994; Kanzler B. et al., 1998). After 
sectioning samples were rehydrated and digested with proteinase K (10 μg/ml) at 37ºC 
for 10 minutes. Riboprobe hybridisation was performed at 65ºC ON. Section were washed 
on the next day, incubated with anti-DIG antibody and developed with BM-purple (Roche, 
ref. 11442074001). Images were acquired with a Nikon Eclipse 90i microscope. 
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2.2 Immuno-histochemistry and immuno-fluorescence 
 
2.2.1 Antibodies used for immuno-histochemistry and immuno-fluorescence 
 
Here is an exhaustive list of all the antibodies used for immuno-staining. 
Primary antibodies used: 
target Host 
species 
Concentration 
used 
reference 
GFP Rabbit 1:200 632460 Living Colors 
GFP chicken 1:100 ab13970 abcam 
GFP chicken 1:400 GFP-1010 Aves labs 
c-TnT Mouse 1:200 MS-295 Thermo Scientific 
CD31 Rat 1:100 553370 BD Pharmingen™ 
Wt1 Rabbit 1:200 ab89901 abcam 
Raldh2 Rabbit 1:200 ab96060 abcam 
CD140α Rat 1:100 558774 BD Pharmingen 
SMAcy3 Mouse 1:400 C6198 Sigma 
SM22 Rabbit 1:200 ab14106 abcam 
Prox1 Goat 1:300 AF2727 R&D systems 
Lyve1 Rabbit 1:200 103-PA50S ReliaTech 
Lyve1 Rat 1:100 103-M130 ReliaTech 
ER Rabbit undiluted ab27595 abcam 
β-galactosidase Rabbit 1:500 56031 Cappel 
Periostin Rabbit 1:200 NBP1-30042 novusbio 
Podoplanin Hamster 1:200 10R-P155a Fitzgerald 
Calponin Rabbit 1:200 Ab46794 abcam 
 
 
Secondary antibodies used: 
Species 
reactivity 
Conjugate Concentration 
used 
reference 
Rabbit  633 1:500 A21071 life technologies ™ 
chicken 488 1:500 A11039 life technologies ™ 
Mouse 633 1:500 A21052 life technologies ™ 
Rabbit 488 1:500 A11034 life technologies ™ 
Rabbit 568 1:500 A11036 life technologies ™ 
Rabbit 594 1:500 A11012 life technologies ™ 
Mouse 488 1:500 A11029 life technologies ™ 
Mouse 594 1:500 A11005 life technologies ™ 
Mouse 568 1:500 A11004 life technologies ™ 
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Mouse 488 1:500 A11029 life technologies ™ 
Mouse HRP 1:200 P 0447 Dako 
Rabbit HRP 1:200 P 0448 Dako 
Rabbit Biotin  111-066-003 Jackson 
ImmunoResearch 
  
2.2.2 Whole mount immuno-histochemistry for the detection of clones  
 
To visualize LacZ+ clones in whole mount, β-galactosidase (β-gal) activity staining 
was performed as previously described (Torres, 1997). Embryos were post-fixed in 4% 
paraformaldehyde (PFA).  
To visualise YFP+ clones, hearts went through a two-step process follow: 
-Whole mount immuno-staining (common protocol for immuno-histochemistry and 
immuno-fluorescence) 
Hearts were permeabilised using 0.5% Triton X-100 in PBS overnight (ON) at 4ºC. Hearts 
went through a process of endogenous peroxidase quenching using 0.03% hydrogen 
peroxide (H2O2) in PBS at room temperature (RT). Hearts were then blocked in PBST 
(PBS triton 0.1%) with 10% goat serum for 3 hours at RT. The samples were incubated 
for 3 days with the primary antibody (anti green fluorescent protein, living colors) at 4ºC. 
Samples were washed in PBST for 3 hours and incubated in a biotinylated secondary 
antibody (Jackson ImmunoResearch) for 2 days at 4ºC. Samples were finally washed for 
an extra 3 hours at RT. 
 
-3,3’-diaminobenzidine (DAB) histochemistry (for whole mount and sections) 
 
YFP signal was amplified with the Vectastain ABC Peroxidase kit and detected using the 
DAB Vectastain Elite ABC Kit. All procedures were performed as advised by the 
manufacturer. 
As a result, YFP + cells and LacZ + cells could be observed as brown and blue labels 
respectively. Hearts were then stored in 80% glycerol at 4 °C.  
Kits used: 
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Kit Reference 
Dako liquid DAB + substrate K3468 Dako 
Vector DAB peroxidase substrate SK-4100KI01, Vector Laboratories 
Vector Red alkaline phosphatase kit SK-5100, Vector Laboratories 
Vector VIP  peroxidase substrate SK-4600, Vector Laboratories 
Vectastain Elite ABC HRP Kit PK-6100, Vector Laboratories 
Vectastain ABC Alkaline phosphatase AK-500, Vector Laboratories 
 
2.2.3 Tissue processing for cryo-sectioning 
 
After overnight fixation, tissues were washed seral times in PBS and cryopreserved 
with a solution of in 15% sucrose in PBS overnight at 4ºC. To build gelatin blocks tissues 
were incubated in a solution of sucrose 15% and gelatin 7.5% (Sigma Aldrich) in PBS at 
37ºC for 4 hours. The samples were then embedded in the same solution at RT. Gelatin 
blocks were left to cool down at 4ºC and snap-frozen in a solution of isopentane at -70ºC 
for 1 minute. Blocks were then stored at -80ºC until cryo-sectionning. 8 μm-thick cryo-
sections were obtained using a Leica CM1950 Automated Cryostat. Sections were 
collected on Superfrost+ slides (Fisherbrand) and stored at ‐20ºC on short term or ‐80ºC 
for the long term. 
 
2.2.4 Immuno-histochemistry on gelatin sections 
 
If slides had been stored in the cold, they were left to sit at 4ºC before being put at 
Room temperature. Immuno-staining was usually performed on freshly cut gelatin 
sections. Slides were incubated at 37ºC in PBS for 15 minutes to remove the gelatin and 
washes several times with PBS. 
Immuno-histochemistry on sections followed the same steps as whole mount 
immuno-staining to the only difference that times of incubation were shorter. 
Permeabilization was performed between 10 and 30 min depending on the targeted 
antigen. Peroxidase block as well as protein blocks were performed for 30min each. All 
procedures were spaced by 3 times washes in PBST. After a final wash with PBS, sections 
were mounted with aquatex (108562 Merck) or dako fluorescence mounting medium 
(S3023). 
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To identify clones by immuno-histochemistry on sections the following kits were used. 
 
2.2.5  Immuno-fluorescence 
 
Tissues were fixed overnight at 4 °C in 2% paraformaldehyde in phosphate-
buffered saline (PBS). For immunofluorescence on sections, tissues were gelatin-
embedded and cryo-sectioned (method described in further chapters). All the steps to 
perform immuno-fluorescence in whole mount or on sections were the same as in the 
immuno-staining section in the previous chapter. We will only list the differences: 
- Peroxidase quenching was performed only in the case of using HRP-conjugated 
secondary antibodies followed by a peroxidase detection-based tyramide fluorescent 
amplification kit. Here is a list of the tyramide kits used: 
Fluorophore Concentration used reference 
TSA plus Cyanine 3 1:100 NEL744001KT, Perkin Elmer 
TSA plus Cyanine 5 1:100 NEL745001KT, Perkin Elmer 
TSA plus Cyanine 5.5 1:100 NEL766001KT, Perkin Elmer 
TSA plus Fluorescein 1:100 NEL741001KT, Perkin Elmer 
 
-The universal TNB blocking reagent (FP1012) Perkin Elmer was used instead of 
goat serum to block unspecific proteins. 
 -For biotin-streptavidin based amplification, streptavidin proteins conjugated with 
a fluorophore were used after incubation with a biotinylated secondary antibody. Here is 
a list of the streptavidin conjugates used: 
Fluorophore Concentration used reference 
Cy3 1:300 016-160-084, JacKson ImmunoResearch 
647 1:300 S21374, ThermoFisher 
633 1:300 S21375, ThermoFisher 
405 1:300 S-32351, ThermoFisher 
 
- Embryos were mounted in Vectashield mounting medium (Vector 
Laboratories,USA). 
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3. Epicardial and arterial mesothelial dissection 
 
We will describe the common steps for the mesothelial dissection of samples used 
for RNAseq and embryonic heart culture together. The major differences between both 
experiments were the nature and the temperature of the solutions used. To preserve 
RNAs, all solutions were ice-cold PBS, were sterile and RNAse free. For tissue culture we 
used a dissection medium at 37 ºC (conditions described later). Samples were dissected 
under a Leica MZ12F stereoscope. The hearts were placed in the appropriate solution 
and frankly cut at the border between the great arteries and myocardium. Each piece was 
placed in distinct petri dishes. Samples for RNA extraction and for tissue cultures were 
handled differently. In the first case, petri dish plates with a bed of 2% agarose/PBS and 
thin metal thread were used to pin down the samples. In the latter case, only the forceps 
were used to delicately handle embryonic hearts. In both cases, fine forceps (Dumont #55 
No11255-20) were used to delicately lift the mesothelium layer of the great arteries or the 
epicardium. The forceps were then used to maintain the embryonic tissues in place while 
carefully peeling the mesothelial/sub-mesothelial layers (form one sheet). The entire 
mesothelium of the ventricle, atrium and OFT was collected for RNA extraction and placed 
into different eppendorf tubes kept in dry ice. For culture, only a small piece of 
mesothelium was harvested at the time. 
 4.Ex vivo explants and culture 
 
Hearts were dissected in 10% Calf Serum in DMEM/F12 1% Penicillin-
Streptomycin kept in a water bath at 37 ºC when not in use. E14.5 Wt1-Cre; R26-mTmG 
Fluorescent hearts and their WT littermates, observed with a Leica MZ12F stereoscope 
(fitted with a fluorescent lamp), were placed in different petri dishes. The medium was 
replaced every 5 min to prevent cooling of the embryonic tissue. One heart was dissected 
at the time under the stereoscope. Meanwhile, the rest of hearts were placed in Petri 
dishes with dissection medium on a histology flat table set at 37 ºC. In WT hearts, a small 
piece of epicardium was peeled off from the ventricle under the PA (as described 
previously). A piece of Pulmonary mesothelium was then placed on the naked 
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myocardium of the recipient WT heart. As a control, a homotypic piece of epicardium from 
a fluorescent donor was placed on the naked myocardium of WT recipients instead. 
Right after dissection, the E14.5 transplanted hearts were placed in a solution of 
49.5% Krebs Henseleit Buffer (with DMEM/F12 instead of water) and 49.5% in Mouse 
serum (supplemented with N2 1:200 and B10 1:50 )1% Penicillin-Streptomycin. Hearts 
were cultured in rolling-bottles in a 5%CO2/ 95%O2 gas environment for three days. Three 
hearts were cultured per bottle separating AMC-transplanted hearts from epicardium-
transplanted hearts. 
Hearts were finally washed in PBS and fixed in PFA 2% PBS ON at 4 ºC. 
 
5. Tissue imaging 
 
5.1 Tissue clearing for 3D imaging 
 
 To detect superficial signal, tissues were dehydrated in gradual concentrations of 
glycerol (20%, 40%, 60% 80%). 
For thick samples or deep signal, tissues were cleared with cubic 1 solution as 
described in the literature (Susaki et al., 2014). 
5.2 Microscopy Imaging 
 
Whole mount tissue and sections were imaged with the following microscopes: 
- With a Leica SP5 multiline inverted confocal microscope for E16.5 and P0 
fluorescent hearts in whole mount. 
- With a Leica SP8 inverted confocal and white light laser for all embryonic 
fluorescent sections. The white laser allows for excitation of all possible wavelengths 
between 405 and 670nm. 
- With a Leica TCS SP8 coupled to a DMi8 inverted confocal microscope Navigator 
module and white light laser. We used this microscope to couple to acquire several 
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embryonic hearts from a same experiment together (E15.5 RA induced animals, E16.5 
Raldh2 KO embryos and E17.5 isl-Cre hearts) 
- With Zeiss LSM 780 multifoton upright microscope. A MaiTai laser line at 1000 
nm was used for two-channel two-photon imaging of Td-tomato and GFP fluorescence of 
E15.5 and E16.5 hearts in whole mount. 
Maximum intensity Z-projections of whole hearts were acquired using both the tiling 
and z-stack functions. 
6.RNA extraction and RNA sequencing: 
 
Upon dissection epicardial and arterial mesothelial tissues were snap-frozen in 
Eppendorf tubes placed on dry ice. For a same mouse litter, the epicardium of either the 
Ventricle or atria and the arterial mesothelium were pooled together respectively. RNA 
was then purified from each population using the RNeasy Micro kit (Qiagen). Stranded 
RNA-seq libraries were sequenced on an Illumina HiSeq 2500 system. Sequencing reads 
were pre-processed by means of a pipeline that used FastQC, to asses read quality, and 
Cutadapt to trim sequencing reads, eliminating Illumina adaptor remains, and to discard 
reads that were shorter than 30 bp. The resulting reads were mapped against the mouse 
transcriptome (GRCm38, release 76; aug2014 archive) and quantified using RSEM v1.17. 
Data were then processed with a differential expression analysis pipeline that used 
Bioconductor package limma for normalization and differential expression testing, defining 
blocks of samples obtained from the same tissue source. Six biological replicates for each 
population were obtained and analysed by RNA-sequencing. 
 
7.RNAseq analysis 
 
The raw data analysis of RNA-seq data were generated by CNIC Bioinformatic unit. 
Contaminant were eliminated from reads using the Cutadapt software (Martin, 2011). The 
resulting reads were mapped and quantified on the transcriptome (Ensembl gene-build 
70) using RSEM v1.2.3 (Li and Dewey, 2011). Only genes with at least 2 counts per million 
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in at least five samples were considered for statistical analysis. Data were then normalized 
and differential expression tested using the Bioconductor package EdgeR (Robinson et 
al., 2010). Genes were considered as differentially expressed genes with a Benjamini-
Hochberg adjusted P-Value ≤ 0.05. Analysis of the data was performed using Gene set 
enrichment analysis and Ingenuity pathways analysis software (Biobase International). 
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Discussion 
 
The work presented in this thesis brought insights into the lymphangiogenic 
properties of SHF progenitors, the role of the arterial mesothelium and the developmental 
dynamics of cardiac lymphatic vessels.   
 
Existence of a niche of LEC progenitors in the pulmonary artery 
 
Our results suggest the existence of a vascular niche of mesodermal progenitors 
in the wall of the pulmonary artery. Interestingly, lymphatic endothelial cells form in close 
proximity to arterial mesothelial cells and epicardial cells. RNAseq and 
immunofluorescence data showed an abrupt downregulation of Raldh2 expression in 
proximal AMCs compared to epicardial cells. In addition, clonal analysis data reveal that 
LECs adopt distinct behaviours depending on their position in the PA and ventricle. LECs 
found at the base of the pulmonary artery are located in the sub-mesothelial portion of the 
PA. However, the cells that have reached the ventricle are visible in the epicardial layer. 
Interestingly SHF-EpiCs are not of mesothelial nature since they are Prox1 +/Wt1-. LECs 
are most likely specified in a low Retinoic acid environment in the proximal PA and 
subsequently migrate down the ventricle where they receive high retinoic acid cues from 
the epicardium, which stimulates lymphangiogenesis.. Consistently, Raldh2 mutant 
embryos presented dilated cardiac lymphatic vessels and reduced branching. In contrast, 
animals injected with RA presented thinner vessels and a hyper-remodelled lymphatic 
vasculature. These data are consistent with previous reports showing the need of RA 
signalling for lymphatic maturation (Bowles et al., 2014; Burger et al., 2014; Marino et al., 
2011). The stronger phenotypes observed in the ventral part of hearts treated with RA 
could be explained by a “short-circuiting” effect on the specification and expansion of SHF-
derived lymphatic progenitors.  We suspect that RA inhibits the specification of LEC SHF 
progenitors in the PA by disrupting the low Raldh2 environment at the base of the PA. 
This would explain why the lymphatic tree of the ventral part of the heart exhibit smaller 
vessels. These data together with the existence of sparse ventral clones in the random 
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clonal analysis, suggests that the lymphatic vasculature which forms by angiogenesis 
from the CV in the ventral part of the heart serves as a scaffold for the later addition of 
SHF-derived LECs. Indeed, the ventral lymphatic vasculature of RA treated hearts 
seemed “naked”. It would be interesting to check whether RA directly affects the 
specification and development of LEC-SHF progenitors by exposing isl1-Cre embryos to 
an excess of RA . 
RA also seems to promote the maturation of cardiac lymphatics since the lymphatic 
sac-like structures in the PA are not maintained in an immature state in untreated animals. 
This area normally exhibits Low Raldh2 levels. The exposition to RA seems to cause 
hyper-remodelling and maturation of PA lymphatic sac-like cells suggesting that low RA 
levels are meant to maintain lymphatic cells in an immature state. 
LEC progenitors may also be under the influence of crosstalk signals between SHF 
progenitors and cardiac neural crest cells (CNCCs). On one hand, SHF progenitors 
express the transcription factor Tbx1 among others. Tbx1 has been shown to be critical 
for lymphatic development by regulating the expression of VEGFR3 (Chen et al., 2010). 
The observation of an aggravated phenotype in the ventral lymphatic vasculature of Tbx1-
null embryos translates specific alterations in SHF-progenitors. Indeed, Tbx1 is critical for 
the deployment of SHF progenitors in the OFT (Jerome and Papaioannou, 2001; Rana et 
al., 2014; Theveniau-Ruissy et al., 2008). On the other hand, CNCCs are a known source 
of molecular cues such as Neuropilin, BMP, Wnt, ephrin, TGFβ/BMP and semaphorin 
signalling. (Feiner et al., 2001; Hutson and Kirby, 2007; Kawasaki et al., 1999; Kuriyama 
and Mayor, 2008). Interestingly, some of these signals are also involved in the 
specification and maturation of lymphatic vessels such as neuropilin, semaphorin and 
Ephrin signalling (Bouvrée et al., 2012; Davy and Soriano, 2007; Jurisic et al., 2012; 
Ochsenbein et al., 2014).  No link has been established between the presence of neural 
crest cells and LECs in the OFT. In the laboratory we ruled out an eventual cell contribution 
of CNCCs to OFT lymphatic cells by fate mapping of Wnt1+ progenitors (Fig. 19). 
However, neural crest cells have been shown to be involved in lymphatic development 
(Burger et al., 2014). It is thus possible that signals from the neural crest are acting on the 
specification of a lymphangiogenic niche in the Pulmonary artery.  The behaviour adopted 
by LECs in the PA and ventricle might be linked to CNCC maturation and migration. 
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Lymphvasculogenesis might be regulated by AMC factors other than RA signalling. 
RNAseq data show that AMCs and sub-mesothelial cells express lymphatic genes such 
as Foxc1 and Foxc2. Interestingly the arterial genes Hey1 and Hey2 were inhibited. These 
data suggest that AMCs might promote the specification of sub-mesothelial cells towards 
a lymphatic fate by the inhibition of arterial genes and the expression of lymphatic genes. 
Data from the chick are consistent with the existence of lymphangiogenic signals 
in the great arteries. Indeed, Wilting and colleagues grafted the proepicardium of quail 
donors into chick embryos to see if LECs could derive from the proepicardium (Wilting et 
al., 2007). The graft constantly failed to produce LECs when transplanted orthotopically, 
indicating a non-proepicardial origin of the cardiac lymphatic vasculature. However, when 
the grafts were transplanted at the base of the heart, they integrated the chick lymphatic 
vessels, indicating an environment that promoted lymphatic specification in this area. 
 
 
A Role for AMCs in lymphangiogenesis? 
 
Figure 19. CNCCs progenitors do not form LECs in the OFT of the heart 
Z projection of a Wnt1-Cre; R26-GFP heart at E14.5. The neural crest lineage is visible in 
green. We cannot observe LECs nor AMCs. Scale bar: 100m 
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We showed that clones containing AMCs are of different nature depending on their 
proximity to the heart. Interestingly, about 20% of AMC clones are composed of both 
proximal and distal cells. Therefore, the addition of SHF-derived mesothelial cells to 
arteries is a continuum, without a strict lineage relationship along the arteries. The 
specification and contribution of AMCs to the great arteries is probably dependent on 
differential environmental cues along the great vessels. The fact that the cell behaviour of 
distal clones could be recapitulated with the Wt1cre line, but no LECs were found in the 
Wt1 lineage suggests that LECs do not arise from AMCs unless a rare subset of AMCs 
not expressing Wt1 would give rise to LECs, however we have not been able to detect 
clones establishing this relationship.  In contrast, clones were found containing LECs both 
in the sub-epicardial end epicardial layer in the OFT myocardium.  The temporal evolution 
of such clones suggests that LECs specified at the base of the aorta later colonize the 
myocardial area and eventually some of them emerge to the epicardial layer. 
Early ventral lymphatic clones at E14.5 and E15 are composed of proximal arterial 
mesothelial cells. In contrast, later ventral lymphatic clones did not exhibit proximal AMCs. 
In some cases, we observed distal mesothelial cells instead. The fact that distal AMCs 
could be observed shows that such clones arose from SHF progenitors capable of giving 
rise to both distal and proximal clones. Proximal mesothelial cells are most likely 
incorporated into the pulmonary artery, reflecting a high turnover of the proximal sheet of 
arterial mesothelial cells. RNAseq data support such conclusions since the EMT actors 
Twist1 and Twist2, are up-regulated in AMCs compared to epicardial cells. In addition, 
only in rare cases did the mesothelial cells of PA explants stayed on the epicardial surface. 
Instead Wt1+ cells consistently invaded the myocardium. 
 
 We have shown that Wt1+ AMCs are not integrated into the lymphatic vasculature. 
However, RNAseq and immunofluorescence data show that Wt1 is downregulated in the 
arterial mesothelium. As a result, some AMCs might be expressing low or undetectable 
levels of Wt1. In that case, we cannot rule out that such cells may be incorporated into the 
cardiac lymphatic vasculature. Interestingly, lineage tracing with the Wt1-Cre transgene 
resulted in the labelling of a substantial number of cells associated to the lymphatic 
vessels (Fig. 20A). In addition, performing isl1-Mer-Cre-Mer lineage tracing we found cells 
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lining against lyve1+/prox1+ cells (Fig. 20B). The study of lymphatic clones in whole mount 
also showed the presence of Prox1-/Lyve1- cells lying against LECs (Fig. 20C).  These 
findings suggest that proximal AMCs are converted into LEC-associated cells. Collector 
and pre-collector lymphatic vessels in the body are coated by a layer of smooth muscle 
cells acquired during late post-natal life. In the region of the heart, lymphatic smooth 
muscle cells (LMCs) appear at first around LECs of the great arteries. It is only during 
adult life that cardiac LMCs can be appreciated (Juszyński et al., 2008). There is no 
evidence for the presence of LMCs in the embryonic heart (Flaht-Zabost et al., 2014). 
AMCs might thus mature into LMCs during late post-natal life. These cells may be similar 
to the pericytes found on capillary blood vessels.  
 
 
 
 
 
 
A                     B                     C 
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What about the Aorta? 
 
The mesothelial proximal clones containing lymphatic endothelial cells are 
localised in the pulmonary artery. However, some proximal AMC clones could also be 
found in the Aorta. Therefore it is not clear if aortic proximal clones also possess 
lymphangiogenic properties. One way to address that issue would be to transplant the 
aortic sub-mesothelium/ mesothelium from fluorescent donors onto the ventricle of WT 
hearts and see if lymphatic vessels form. Prox1 and Lyve1 immunostaining in whole 
mount, show that lymphatic vessels generally form in the area corresponding to the 
territory of PA proximal lymphatic clones (Fig. 21A). However, in few individuals, the 
primary arterial lymphatic plexus appeared connected to the aorta (Fig. 21B). In addition, 
the unique ventral P0 clone we found, on the ventral part of the heart, displayed lymphatic 
cells on both the Ao and PA. We think that LEC progenitors specify in the PA, but some 
inter-individual variations may cause LECs to form at the base of the Aorta instead. 
 
Figure 20. AMCs might be a source of LMC-like cells 
(A) Heart section showing Wt1-Cre lineage in green (B) Heart section of an ils1-Mer-Cre-Mer 
heart induced at E9 (C) Z projection of a specimen from the clonal analysis with focus on the 
base of the Pulmonary artery (PA). We can see lymphatic vessels in all three panels. The 
arrowheads point at Lymphatic smooth muscle-like cells (LMC-like). 
PA: Pulmonary artery; RV: Right ventricle; LECs: Lymphatic endothelial cell; AMCs: Arterial 
mesothelial cell 
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The heterogeneous origins of the cardiac lymphatic vasculature  
 
We will firstly discuss the results reported by the group of Paul Riley in 2015 because their 
work is the only study currently available on the origin of cardiac lymphatic vessels (Klotz 
et al., 2015). 
Using the Tie2-Cre transgene, Linda Klotz and colleagues concluded that the 
cardinal vein is not the only source of cardiac lymphatic vessels. Despite exhaustive 
recombination of CV cells in Tie2-Cre embryos, the team reported incomplete 
recombination of the cardiac lymphatic vasculature. They confirmed these observations 
using the Tie2-Cre transgene to drive Prox1 deletion using a Prox1flox/flox allele. Prox1 is a 
master regulator of lymphatic development indispensable for lymphatic formation 
(Johnson et al., 2008). Consequently, deleting prox1 from the Tie2 lineage is an effective 
Figure 21. Morphology of the cardiac lymphatic vasculature at the level of the great 
vessels 
(A,B) Z- projection of the frontal view of a hearts at E16.5 with focus on the great arteries. The 
cardiac lymphatics can be appreciated by the markers Lyve1 (red) and prox1 (green).  (A) Most 
common situation. The primary lymphatic plexus usually forms on the Pulmonary artery 
(arrowheads). (B) in exceptional cases the primary lymphatic plexus forms on the Aorta 
(arrowheads). All scale bars: 100m. Ao: Aorta; PA: Pulmonary artery;  
 
A                                        B 
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way to inhibit lymphangiogenesis in cardinal vein progenitors. As a result, the cardiac 
lymphatic vasculature of mutant embryos was hypoplastic. Therefore, the cardinal vein 
cannot be the sole source of lymphatic vessels or no lymphatic vessels would appear in 
the heart. It cannot be excluded that a portion of cardiac LECs may derive from incomplete 
gene deletion in a subset of CV cells. Another alternative is the existence of non-venous 
progenitors capable of forming LECs in the heart. Our discovery, placing the SHF as a 
key contributor of cardiac LECs, fits with these observations. 
Linda Klotz and colleagues used a range of tissue-specific Cre lines to determine 
the origins of cardiac LECs. In particular, they used Mesp1-Cre and Nkx2.5-Cre to trace 
the fate of early and late mesodermal progenitors  (Lints et al., 1993; Saga et al., 1999) 
respectively. However, no lymphatic vessels were found to belong to any of these 
lineages. At first glance, this results seem inconsistent with ours since the SHF is a 
mesodermal lineage (Kelly et al., 2001)(Saga et al., 2000)(Saga et al., 2000)(Saga et al., 
2000). We have to keep in mind that the use of Mesp1-Cre or Nkx2.5-Cre with a 
fluorescent reporter result in strongly fluorescent hearts, because the entire myocardium 
is recombined. It is then difficult to observe the lymphatic vasculature by direct 
visualization at the stereoscope. In order to detect recombination in LECs Klotz and 
colleagues used confocal microscopy, however, to find SHF-derived cardiac lymphatics, 
a specific study of the ventral side of the heart is required.  
In addition, ventral LEC progenitors in the SHF may not recombine efficiently, since 
the Nkx2.5Cre line does not completely recombine the SHF before its incorporation to the 
heart. Moreover, we think that ventral lymphatic cells arise from the latest SHF progenitors 
added to the arterial pole. Consistently, proximal AMC clones can be recapitulated using 
the line Hoxb1-Cre, which labels the posterior SHF arterial pole precursors. The fact that 
we were able to label lymphatics development in the ventral part of the heart using Mef2c-
Cre, and isl1mER-Cre-mER at E9 suggests that lymphatic progenitors are located in the 
posterior region of the anterior SHF, understood as the SHF region that contributes to the 
arterial pole of the heart. This region would be the last added to the arterial pole and 
adjacent to the splanchnic mesoderm that contributes to the base of the great arteries. 
This hypothesis is consistent with the fact that proximal clones are composed of valvular 
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cells as well as cardiomyocytes of the base of the pulmonary artery but not to 
cardiomyocytes in the right ventricle or atria. De Bono and colleagues showed the 
existence of a transitory region at the interface between the AHF and pSHF that 
simultaneously expresses Mef2c-AHF-driven Cre, Tbx1 and Tbx5 (De Bono et al., 2018). 
Complementary fate mapping of Tbx5+ progenitors would provide insights into the exact 
location of LEC progenitors in the SHF. 
 
The existence of alternative sources of cardiac lymphatic cells have been 
suggested by Klotz and co-workers. The group reported possible contribution of  the Yolk 
Sac haemogenic endothelium to the cardiac lymphatic vasculature using Pdgfr-CreERT2 
for lineage tracing (Klotz et al., 2015). However, Ulvmar and colleagues later showed that 
the Pdgfrb-Cre transgene is not appropriate to trace the fate of non-venous progenitors 
as it recombines part of the cardinal vein and jugular lymph sacs (Ulvmar et al., 2016). 
Several recent reports propose alternative origins of the lymphatic cells other than the 
cardinal vein, suggesting that the definitive lymphatic plexus forms both by 
lymphangiogenesis (sprouting off pre-existing vessels) from CV-derived vessels, and 
lymphvasculogenesis (de novo vessel formation) from different sources. Organs like the 
skin and the mesentery form their lymphatic vasculature from endothelial and non-
endothelial progenitors (Martinez-corral et al., 2015; Okuda et al., 2012; Pichol-thievend 
et al., 2018; Stanczuk et al., 2015; Wilting et al., 2006). In addition, there is growing 
evidence that LECs of different organs display different properties and genetic signatures 
(Petrova and Koh, 2018; Ulvmar and Mäkinen). These findings together with our findings 
reconcile the models of Sabin (Sabin, 1902) and Huntington and McClure (Huntington and 
McClure, 1910).  
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The lymphangiogenic properties of SHF progenitors introduce the concept of 
organ-specific lymphatic development 
  
 The discovery that SHF progenitors give rise to cardiac LECs, offers another 
perspective for the study of cardiogenesis and lymphangiogenesis.  
On one hand It shows that the SHF is highly multipotent and is capable to provide 
the heart with nearly all cardiac cell types. We suspect the multipotent properties of SHF 
progenitors to rely on the expression of isl1 transcription factor. Indeed, different reports 
suggest that isl1+ cells in different regions of the embryonic and adult heart are highly 
plastic (Bu et al., 2009; Laugwitz et al., 2005; Moretti et al., 2006; Qyang et al., 2007; Sun 
et al., 2007). It would be interesting to further challenge the contribution of SHF 
progenitors to other cardiac cell types. In addition, dissecting the molecular and cellular 
properties of SHF progenitors might offer new therapeutic strategies for the treatment of 
cardiomyopathies.  
On the other hand, these discoveries imply that studying lymphangiogenesis 
should be done at the organ-level because LECs might derive from tissue-specific 
progenitors. Creating organ-specific LECs in situ, might be a way to create a capillary 
vasculature that fits perfectly the organ needs and environment. Indeed, LECs from 
different sources of progenitors may not be equivalent in terms of function (Petrova and 
Koh, 2018; Ulvmar and Mäkinen). In contrast, venous-lymphatic sprouting most likely 
creates collecting vessels meant to link the different organ plexuses to the thoracic duct. 
The reason why SHF-derived LECs exclusively form in the ventral part of the heart is not 
clear. It might be because the OFT region of the heart is a source of intense remodelling, 
it may be more “practical” to dispose of all OFT progenitors in a same location, however, 
specific disruption of this SHF-derive Lymphatic population would be required to 
determine whether and how they may play a specialized function in heart lymphatics. 
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Conclusions 
 
 
1) Arterial mesothelial cells do not derive from the proepicardium but from the Second 
heart field. 
2) The second heart field partially contributes to the smooth muscle and endothelial cells 
of the great vessels through contribution of arterial mesothelial cells. 
3) In the pulmonary artery, proximal AMCs are clonally related to the lymphatic 
vasculature of the ventral part of the heart. 
4) Proximal AMCs neither give rise to LECs nor to cardiomyocytes. 
5) Most of the lymphatic cells of the dorsal part of the heart and part of the lymphatic cells 
of the ventral part of the heart are formed by angiogenesis of Cardinal vein progenitors. 
6) The lymphatic vasculature of the ventral part of the heart depends on the late 
specification of SHF progenitors. 
7) SHF progenitors are recruited in the mesothelial/sub-mesothelial region of the 
Pulmonary artery and colonize the ventricles by lymphangiogenesis. 
8) The specification of LECs of the ventral part is conducted in a Raldh2 low environment. 
9) RA signalling is involved in the subsequent remodelling of the lymphatic vasculature in 
the ventricles. 
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